Next Article in Journal
Study of Class 1, 2, and 3 Integrons, Antibiotic Resistance Patterns, and Biofilm Formation in Clinical Staphylococcus aureus Isolates from Hospital-Acquired Infections
Previous Article in Journal
Fatal Paraclostridium sordellii Infection: Post-Mortem Assessment and Review of the Literature
Previous Article in Special Issue
Hepatitis E Virus (HEV) Infection among Hemodialysis Patients from Southern Bulgaria
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review

by
Sophie Deli Tene
,
Abou Abdallah Malick Diouara
*,
Sarbanding Sané
and
Seynabou Coundoul
Groupe de Recherche Biotechnologies Appliquées & Bioprocédés Environnementaux (GRBA-BE), Laboratoire Eau—Énergie—Environnement—Procédés Industriels (LE3PI), École Supérieure Polytechnique (ESP), Université Cheikh Anta Diop (UCAD), Dakar 5085, Senegal
*
Author to whom correspondence should be addressed.
Pathogens 2025, 14(7), 704; https://doi.org/10.3390/pathogens14070704
Submission received: 31 May 2025 / Revised: 13 July 2025 / Accepted: 14 July 2025 / Published: 16 July 2025

Abstract

Hepatitis E virus (HEV) is a pathogen that has caused various epidemics and sporadic localized cases. It is considered to be a public health problem worldwide. HEV is a small RNA virus with a significant genetic diversity, a broad host range, and a heterogeneous geographical distribution. HEV is mainly transmitted via the faecal–oral route. However, some animals are considered to be natural or potential reservoirs of HEV, thus elucidating the zoonotic route of transmission via the environment through contact with these animals or consumption of their by-products. Other routes of human-to-human transmission are not negligible. The various human–animal–environment entities, taken under one health approach, show the circulation and involvement of the different species (mainly Paslahepevirus balayani and Rocahepevirus ratti) and genotypes in the spreading of HEV infection. Regarding P. balayani, eight genotypes have been described, of which five genotypes (HEV-1 to 4 and HEV-7) are known to infect humans, while six have been reported to infect animals (HEV-3 to HEV-8). Furthermore, the C1 genotype of the rat HEV strain (HEV-C1) is known to be more frequently involved in human infections than the HEV-C2 genotype, which is known to infect mainly ferrets and minks. Contamination can occur during run-off, flooding, and poor sanitation, resulting in all of these genotypes being disseminated in the environment, contaminating both humans and animals. This systematic review followed the PRISMA guidelines and was registered in PROSPERO 2025 CRD420251071192. This research highlights the importance of investigating the transmission routes and major circulating HEV genotypes in order to adopt a holistic approach for controlling its emergence and preventing future outbreaks. In addition, this article outlines the knowledge of HEV in Africa, underlining the absence of large-scale studies at the environmental, human, and animal levels, which could improve HEV surveillance on the continent.

1. Introduction

Hepatitis E virus (HEV) is a public health concern causing large outbreaks and sporadic cases of acute hepatitis around the world [1]. The World Health Organization (WHO) estimated that 20 million people are infected with HEV worldwide each year, resulting in about 3.3 million symptomatic cases of hepatitis E. In 2015, this led to approximately 44,000 deaths, accounting for 3.3% of the mortality due to viral hepatitis [1,2]. HEV infection is the most or second most common cause of acute viral hepatitis among adults in much of Asia, the Middle East, and Africa [3,4]; however, the actual burden of HEV infection remains unknown [5]. HEV is a small single-strand positive-sense RNA virus belonging to the Hepeviridae family, which is divided into two subfamilies, namely Orthohepevirinae and Parahepevirinae, and five genera (Avihepevirus, Chirohepevirus, Paslahepevirus, Rocahepevirus, and Piscihepevirus) [6]. Orthohepevirinae infect mammals and birds, while Parahepevirinae infect fish. Ten species have been described to date: A. magniiecur, A. egretti, C. eptesici, C. rhinolophi, C. desmoid, P. balayani, P. alci, R. ratti, R. eothenomi, and P. heenan [6,7]. Among the listed species, two have been identified as emerging and therefore of public health concern, namely, Paslahepevirus balayani and Rocahepevirus ratti. The genetic diversity of Paslahepevirus balayani species includes eight genotypes (HEV-1 to HEV-8) with a very heterogeneous worldwide distribution and a broad host range with different prevalence rates depending on the affected animal species, sampling region, or breeding system [8]. It is known that five of the above-mentioned HEV genotypes (HEV-1 to 4 and HEV-7) cause hepatitis in humans [9]. HEV-1 and HEV-2 are found only in humans and are predominant in low-income Asian and African countries. Outbreaks have mainly occurred via the faecal contamination of drinking water due to poor water hygiene and sanitation and contaminated water supply [10,11,12,13]. There is considerable epidemiological evidence of waterborne HEV transmission, especially in Southern/Southeast/Central Asia and Northwest Africa [11,14,15]. HEV-3 and HEV-4 are found in humans and more frequently in animal, including domestic pigs, wild boar, deer, and rabbits [16]. Sporadic cases of autochthonous HEV have been reported in many developed countries by contact with infected animals, mainly after the consumption of raw and undercooked meat products [17]. These include infected pork liver, pork products containing liver, and other pig meat consumed raw or undercooked, which underlines direct evidence of zoonotic HEV transmission [18,19,20]. HEV-5 and HEV-6 were observed among wild boars in Japan; HEV-7 was identified in Dromedary camels in the Middle East; and genotype 8 was identified among Bactrian camels in China [21,22]. Only one human infection with HEV-7 was reported to be due to consuming contaminated camel meat and milk [23]. In addition, recent studies have reported the involvement of the Rocahepevirus ratti (rat HEV) species in the zoonotic transmission of HEV, especially in immunocompromised patients and in transplant recipients [24,25,26]. Among rat HEV genotypes (including HEV-C1 and HEV-C2), HEV-C1 has been reported to be responsible for human infections, with the first human case identified in Hong Kong caused by HEV-C1 [27,28]. This genotype also accounts for the majority of human infections reported cases with rat HEV. However, although identified in its carnivorous hosts (ferrets and minks), the zoonotic transmission of HEV-C2 is described as rare and not well studied [29]. Globally, despite reported human cases, the routes of transmission of rat HEV to humans, as well as exposure factors, remain unclear and undetermined. The expanded host range and animal reservoirs indicate these HEV strains’ high variability and zoonotic potential [16,30]. Furthermore, HEV shed by infected animals can contaminate water irrigation sources and lead to the accumulation of HEV in fruits and vegetables [18]. Infectious HEV has also been found in swine manure and wastewater [31]; therefore, applying manure to land and subsequent runoff could contaminate coastal water, leading to shellfish contamination and, subsequently, possible human infection. HEV-3 RNA has been detected in red fruit, strawberries, salad greens, and spices [32], as well as in oysters and mussels [33]. Other transmission routes have also been documented, including blood transfusion and tissue transplantation in immunocompromised patients [34,35,36,37,38,39]. Studies from developed countries have shown asymptomatic viremia (HEV-RNA) in blood donors, suggesting ongoing subclinical infection [40,41]. To mitigate this transmissibility, several developed countries have adopted measures to enhance blood safety based on the epidemiology of HEV [18,42,43].
Cases of hepatitis E infection are often asymptomatic, self-limited, and rapidly resolving in immunocompetent individuals. As a result, mortality rates observed in the general population are relatively low, ranging from 0.5 to 4% [44,45,46,47]. However, severe forms of the infection occur in different groups of vulnerable populations, including pregnant women, immunocompromised persons, and people with pre-existing chronic liver disease, leading significant mortality [3,48,49]. High mortality rates of up to 30% have been reported in pregnant women, particularly during the third trimester of pregnancy. Due to their vulnerability, they are more likely to develop complex forms of the disease. In addition, cases of preterm delivery, low birth weight, and stillbirth of the foetus or newborn have been documented [50,51,52].
The first documented outbreak of HEV infection in Africa likely occurred in 1950 in Tunisia [53]. In a systematic review of African studies, at least 17 outbreaks were reported in Africa about once every other year since 1979 in 28 countries out of 54, causing a reported 35,300 cases with 650 deaths [45,54]. The most recent epidemics reported in Africa occurred in 2017 (Niger, Nigeria, and Chad) and 2018 (Namibia) [55]. On the other hand, Modiyinji et al. conducted a systematic review of the prevalence of HEV in animals in Africa, highlighting that some animals could be the reservoir of HEV and suggesting the need for molecular epidemiological studies for investigating zoonotic transmission in Africa [56,57].
To date, published reviews in Africa have focused solely on the epidemiology of HEV in humans [54] or animals [56]. To our knowledge and based on our literature search, no previous review in Africa considers human, animal, and environmental factors together in a one health context when studying the epidemiology of HEV. There is a lack of reviews that provide an overview of HEV epidemiology in Africa covering these three aspects. To address these critical gaps, this systematic review aims to explore the epidemiology of HEV from a one health perspective. It will mainly focus on the presence of HEV in drinking water, wastewater, domestic fauna, and the population of blood donors.

2. Methods

A literature search was conducted in PubMed. Systematic reviews, meta-analyses, original articles, and reviews were screened from this database between 2004 and 2024. The following set of keywords was used in combination to retrieve these articles: HEV, Hepatitis E, non-A, non-B, epidemiology, blood donor, food, wastewater, drinking water, and agriculture (Table 1). Only documents published in English with an abstract and full text were used. Articles were excluded based on their title and abstracts or considered irrelevant to this review or related to similar subjects. For manual records, additional keywords such as “one health” and “Africa” were used. For completeness, additional relevant articles have been included, mainly those relating to rat HEV, which is now an emerging cause of hepatitis E infection. The search process is summarized in Figure 1 as a flowchart generated according to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines. This systematic review was registered in PROSPERO 2025 CRD420251071192 and is available from https://www.crd.york.ac.uk/PROSPERO/view/CRD420251071192 (accessed on 11 June 2025).

3. Taxonomy, Genetic Features and Global Distribution of HEV

HEV is a hepatotropic virus with a genome length of approximately 6.4–7.2 kb. The genomic architecture indicates a single-stranded RNA virus of positive polarity, with a cap of 7-methylguanosine at its 5′ end and polyadenylated at its 3′ end. The genome structure comprises three Open Reading Frames (ORFs) [58]. A fourth open reading frame (ORF4) (embedded within ORF1) present in only genotype 1 strains has also been described and overlaps with ORF1 [59,60,61]. ORF1 at the 5’ end of the genome encodes the non-structural polyprotein, while ORF2 encodes the capsid protein at the 3′ end of the viral genome. ORF3 encodes a small multifunctional, phosphorylated, and palmitoylation protein consisting of 113 or 114 amino acids (aa) [60,62,63] and overlaps with the 5′ end of ORF2. This overlapping region is highly conserved and can be used for the molecular detection of HEV RNA [9,64,65]. Additionally, the 5′ end of the viral genome acts as a binding site for the viral RNA-directed RNA polymerase (RdRP), is also highly conserved, and can therefore be used as a target for molecular detection [66].
In the infected host, HEV exists in two forms: non-enveloped virions (neHEVs) 27–34 nm in diameter when secreted in faeces and bile and quasi-enveloped (eHEV) particles in circulating blood and infected cell culture supernatants [58,67]. The eHEV particles are covered by a lipid envelope, improving bloodstream survival and virion entry, while neHEV is known to be the most infectious form of HEV. This last one is also more stable in bile and faeces environments, enabling transmission via the faecal–oral route [68]. The existence of these two forms allows HEV to evolve in different environments.
The major HEV strain infecting humans is classified in the genus Paslahepevirus, belonging to the family Hepeviridae, subfamily Orthohepevirinae [7], and can be further divided into two species: Paslahepevirus balayani (formerly known as Orthohepevirus A) and Paslahepevirus alci [8,69].
Eight genotypes have been identified in the P. balayani species, five of which are reported to cause human disease [70,71]. HEV-1 and HEV-2 genotypes are widely dis-tributed. These strains are pathogenic only for humans and are endemic in developing countries where they are responsible for significant waterborne outbreaks in endemic regions of Africa, South and Southeast Asia, and Mexico [61,72]. HEV genotypes 3 and 4 (HEV-3 and HEV-4) are zoonotic strains with animal reservoirs, and a broad host range is known (pigs, cattle, sheep, goats, horses, macaques, cats, dogs, rabbits, mongoose, rats, and mice) and they have a geographical spread around the world. These genotypes of zoonotic HEV cause sporadic and cluster cases in both industrialized and developing countries [44,58,72,73]. Furthermore, local outbreaks caused by HEV-3 and 4 have been reported [74,75,76,77,78]. They can be transmitted to humans mainly through consuming contaminated foodstuffs, including raw and undercooked meat products from the animals mentioned above, because they circulate in both domestic and wild fauna. In addition to the zoonotic transmission route, many studies reported that these genotypes could also be transmitted parenterally via blood and blood products [17,19,79,80]. Two unrecognized and different new genotypes were isolated from Japanese wild boar for the first time and identified as genotypes 5 and 6 [81,82]. In addition to these, two additional HEV genotypes have been identified in dromedaries (DcHEV) and camels (BcHEV), respectively, HEV-7 and HEV-8, further expanding the host diversity of HEV [22,72,83]. These camel HEV genomes possessed >20% nucleotide difference from all other HEVs with complete genome sequences available [84]. HEV-7 is likely to be a causative agent for human hepatitis E infection and has been identified in a man who regularly consumed camel meat and milk [23,82,85,86]. It is important to note that HEV-7 and HEV-8 genotypes were identified in the Middle East and China, respectively. However, the knowledge and geographical distribution of these genotypes remain limited compared to the other genotypes. Figure 2 shows the global distribution of P. balayani genotypes and their overlaps in specific geographical areas.
In addition to the common Paslahepevirus balayani strains causing hepatitis E infections in humans, an emerging HEV species, Rocahepevirus ratti (classified initially as Orthohepevirus C), which is genetically very different, has been identified primarily in rats (Rat-HEV) and other rodents (shrews, ferrets, minks, and wild rodents) [87]. This species has only 50–60% genomic identity and a significant ORF2 sequence divergence compared to P. balayani. Its intra-species diversity shows two main genotypes known as HEV-C1 and HEV-C2, with rodents and carnivores as their respective hosts. Rat HEV strains primarily infect rats but have also been identified as capable of crossing the species barrier and infecting humans, thus presenting a potential risk of zoonotic transmission. However, although HEV-C1 is most frequently involved in human infections, the C1 genotype predominantly comes from rats, while C2 strains originate from ferrets and minks. In addition, two other putative genotypes have been proposed to date, namely C3 and C4 [25], but have yet to be assigned (Figure 3).
The genomic structure of P. balayani is similar to that of other hepeviruses, including Rat-HEV [88], except a single putative ORF identified in some rat HEV strains, the function of which is unclear [89].

4. Phylogenetic Analysis

A set of HEV full-length, near full-length genomes and partial sequences of HEV (ORF-2 for Paslahepevirus genus) and (ORF-1, ORF-2 and ORF-3 for Rocahepevirus genus) were downloaded from GenBank for phylogenetic reconstruction purposes. For each set, all sequences considered are reduced to the same size and cover the genomic region from the nucleotide position [5995 to 6226 (ORF-2) for the Paslahepevirus genus, then 42-4921 (ORF-1), 4949-6883 (ORF-2), and 4938-5246 (ORF-3) for the Rocahepevirus genus] relative to the NC_001434 and NC_038504.1 reference sequence respectively for the Paslahepevirus and Rocahepevirus. Then they are subject to multiple sequence alignment with MUSCLE and gap positions are removed by using the Gblocks program on SEAVIEW software v5.0.4 [90]. Phylogenetic trees were inferred by the maximum likelihood method with PhyML v3.1 [91]. The trees were generated under the best-fit nucleotide substitution model GTR + G + I determined by MODELTEST in MEGA X [92]. The Subtree-Pruning-Regrafting heuristic search was applied for optimal tree topology. Branch supports were determined with 100 bootstrap replicates. The phylogenetic trees were read and edited with Figtree [93] (Figure 4, Figure 5, Figure 6 and Figure 7).

5. Transmission Routes of HEV

Multiple transmission routes are enabling the spread of hepatitis E virus. However, the two main routes of transmission are faecal–oral and zoonotic in developing and industrialized countries, respectively. In addition to these, with all the contaminations that occur directly or indirectly, mother-to-child transmission, human-to-human transmission, and transmission through blood transfusions are often reported and are therefore not negligible. In Figure 8, we summarize the different transmission routes known to date for the circulation of HEV in the environment, in humans and in animals recognized as natural reservoirs of the virus.

5.1. Environment

5.1.1. Drinking Water

Waterborne diseases threaten human health, particularly in low-income countries [94]. According to the WHO, in 2022, at least 1.7 billion people were using drinking water sources contaminated with faeces. The bacterial and viral contamination of drinking water due to faecal contamination poses the most significant risk to drinking water safety [95].
HEV infection is often a waterborne disease associated with epidemics and sporadic cases worldwide, frequently due to HEV genotypes 1 and 2. Hepatitis E virus transmission to humans through water has been largely demonstrated for these genotypes, primarily in developing countries [96]. The leading causes of outbreaks were limited access to or the contamination of drinking water, inadequate sanitation, hygiene, and health services, and the poor disposal and treatment of sewage. In addition to these most frequently reported phenomena, overpopulation, the lack of drinking water, and periodic flooding have been identified as contributors to the hepatitis E outbreak in Southern Sudan in 2023 [97]. A recent systematic review based on a meta-analysis reported a worldwide prevalence of HEV in drinking water of 4.7% [57].
Water transmission is also suspected for the zoonotic genotypes since HEV-3 and HEV-4 have been detected in different environmental waters [96,98,99,100]. An investigation of a tap water-mediated HEV outbreak in China suggests that sporadic cases of waterborne outbreaks of HEV-4 may occur in industrialized countries [101,102].

5.1.2. Wastewater and Surface Water

HEV has been detected in wastewater worldwide, particularly in developing countries, where sanitation and water supply services remain precarious or inaccessible for some populations. HEV is an enteric virus that can be excreted as a non-enveloped particle in the faeces of humans (wastewater) and animals (runoff from slaughterhouses, pig farms, or free-ranging animals) [103]. The faeces shed the virus in high amounts, with a documented amount of up to 1011 viral particles per gram of stool [104,105] and a median peak of approximately 1010 genome copies/g [106,107].
Most of the time, the faeces of HEV-infected animals and humans can reach sewer systems through environmental phenomena such as flooding in rainy seasons, then contaminating municipal wastewater treatment plants (WWTPs), therefore potentially increasing the spread of the virus in the environment [100,102]. On the other hand, livestock and/or slaughter waste (blood, water, faeces, etc.) from these animals, which constitute a zoonotic reservoir for HEV, end up in wastewater in some way. As a result, the inadequate treatment of this water could lead to the severe contamination of the environment and, hence, the emergence of the disease in humans exposed to this wastewater. Usually, these people are the water sanitation and supply services staff. They are at a significant risk of exposure to HEV [108].
Coastal waters can become contaminated by human sewage and manure runoff, and therefore, HEV can accumulate in certain organisms produced close to land [102,109,110,111].
Until 2019, water’s role in transmitting HEV-3 had only been suspected [98]. Given its zoonotic nature, detecting the viral genome in wastewater concerns public health authorities [112].
The global HEV prevalence in water matrices was estimated to be about 15.14% in untreated wastewater, 3.81% in treated wastewater, and 7.46% in surface waters [57]. According to this systematic review, the most predominant genotypes found were HEV-3, followed by HEV-1 and HEV-4. In addition, authors report that HEV in water environments found in Europe (12.2% [7.6–17.7]), Asia (9.9% [0.7–26.2]) and America (6.5% [0.9–15.4]) was all higher than what was found in Africa (0% [0–3.6%]) [57]. This relatively low prevalence of HEV in wastewater in Africa is likely an underestimation, as confirmed by the limited number of studies (n = 03) on HEV testing in wastewater from 1995 to 2020. A recent study in Cameroon revealed an HEV prevalence of 1.9%, and phylogenetic analysis showed that it belonged to genotype 3, subtype 3a, forming a cluster with swine strains [113]. Most recently, in South Africa, HEV was detected in 21.8% (117/536) of the water samples, with detection rates of 22% (72/328) in wastewater influent, 22% (42/188) in river water, and 10% (2/20) in ablution runoff/standpipe site samples. Sequence genotypes belonged to HEV-3 (subtypes 3c and 3f) and HEV-4 (subtype 4b) with the following rates: 98% and 2%, respectively [114].
Furthermore, while the transmission routes of rat HEV are poorly understood, the virus was detected in French urban wastewater samples (11/11), indicating a significant prevalence of Rocahepevirus ratti in the human environment, particularly in urban wastewater [115]. Based on this reported detection, the contamination of wastewater by human faeces, particularly through the existence of asymptomatic cases, must be raised. However, the most plausible hypothesis seems to be the implication of the natural host, mainly rodents, in the sewage system through their dejections, which may reach the urban WWTP. In any case, the detection of Rocahepevirus in the environment through wastewater is likely to have a significant impact on its potential as a new source of human contamination as well as its subsequent environmental spreading [115,116].

5.2. HEV in Foodstuffs

Viruses in food come from the human or animal gastrointestinal tract via excreta and can contaminate water, food, and the environment [13]. Food contamination can occur through direct contact with infected persons or indirectly through contaminated environments, including using contaminated water or faecal matter as fertilizers during food production [107].
Although viruses do not multiply in food, HEV is stable under specific physicochemical conditions, persists for months, and remains infectious [117,118]. According to a recent study, the HEV-3 genotype can survive for a long time at 4 °C, and its infectivity in food was reported to remain at −20 °C, even after 12 weeks of storage. The complete inactivation of HEV-3 has been performed by heating at 56 °C for 1 h or at a higher temperature for a shorter time [119]. On the other hand, studies have also demonstrated that HEV remains stable at 56 °C, and temperatures above 71 °C have been shown to completely inactivate HEV, depending on the genotype and food matrices. Indeed, heating a faecal suspension containing HEV-1 and/or HEV-2 at 71 °C results in complete HEV inactivation.
Furthermore, frying or boiling pork contaminated with HEV-3 and HEV-4 at 191 °C for 5 min ensures complete HEV inactivation in 0.5 to 1.0 cm2 pieces of pork liver. The condition mentioned above (191 °C, 5 min) enables core cooking at an internal temperature of around 71 °C, without burning the tissue. These data are essential, as their application on both industrial and household scales will help guarantee food safety, particularly for meat products, to limit the foodborne transmission of HEV as much as possible [120,121]. Foodborne HEV outbreaks are often associated with zoonotic HEV-3 and HEV-4 strains and are transmitted via the faecal–oral route [30,122].

5.2.1. Seafood Products

As a result of waterborne transmission, contaminated, untreated water and farm and slaughterhouse runoff are potential vehicles of pathogens. Via flooding and other natural phenomena, these waters join watercourses and contaminate shellfish production areas and other aquatic areas [57], mainly when these production areas are located near urban or livestock areas [123].
The consumption of fish and seafood products, particularly edible lamellibranch molluscs (ELMs), is a risk to human health because of their capacity to filter, accumulate, and concentrate pathogens present in the water within their tissues. In certain countries, bivalves and shellfish are tested regularly for faecal contamination using E. coli as an indicator, which is poor for reporting the presence of viral faecal contamination [124].
Shellfish consumption has been identified as a risk factor for hepatitis E in several case reports [125,126] and caused an outbreak of hepatitis E aboard a cruise ship [75]. Bivalves are widely recognized as one of the foods most at risk for HEV contamination, especially when consumed raw or undercooked [117,127]. HEV can also persist in shellfish and marine environments for weeks to months [128,129].
Around the world, several studies have documented high HEV positivity rates in shellfish bivalves, mainly in Asian countries, including China, Japan, and Vietnam [130,131,132] and other countries such as the United Kingdom and Spain [33,111,123]. In South Italia, HEV was detected in sampled shellfish in 1 out of 108, accounting for a positivity rate of 0.9% [105]. A positivity rate of 2.9% (9/310) was also reported in shellfish purchased from local markets in Scotland [133], thus highlighting the possible occurrence of HEV infection in shellfish consumers. In addition, a long viral persistence has been demonstrated in these marine animals, making shellfish significant vectors of enteric diseases, particularly HEV [123,134,135].

5.2.2. Fruit and Vegetables

Fresh vegetables and ready-to-eat (RTE) salads have become increasingly recognized as potential vehicles for foodborne diseases [136,137]. The contamination of fruit and vegetables by enteric viruses can occur during cultivation, before the pre-harvest and post-harvest stages, i.e., from farm to fork. Certain cultivation practices, such as fertilization with faecal matter, methods of watering horticultural produce, and water contaminated by faecal matter used as an input during irrigation, are all major contributors to produce contamination. This transmission route may occur due to insufficient initial washing, inadequate cooking practices, inadequate hygiene by food handlers, and specific cultivation and harvesting methods. In brief, major contamination routes of fresh produce are irrigation water and improper food handler hygiene.
If irrigated with contaminated water, vegetables and berries can retain microbial agents on their surfaces, including enteric viruses [105,138,139,140,141,142]. Therefore, they play an important role in determining environmental and food contamination [105].
HEV was found once in a pack of frozen raspberries taken from a cold room at the point of sale with a reported prevalence of 2.6% [143]. In Europe, Kokkinos et al. found the presence of HEV in 5% of irrigation water samples tested from a leafy green vegetable production chain and in 4 out of 125 fresh lettuce samples, accounting for a positivity rate of 3.2% [32], demonstrating that irrigation water is a significant risk factor for HEV transmission in fresh fruit and vegetables; Purpari et al. reported HEV in vegetable samples with a positivity rate of 1.4% from Sicily, Italia [105]. Other authors have also reported for the first time the detection of swine HEV (HEV-3) in strawberries grown in a field where the irrigation water came from a contaminated river located in agricultural and residential areas. The detection of HEV-RNA in fruits and vegetables underlines the risk of exposure related to the consumption of these products, which are frequently eaten raw. Although less frequent than waterborne epidemics, isolated or clustered cases linked to the ingestion of contaminated fruit and vegetables are possible but do not lead to major outbreaks and are therefore not significant.

5.2.3. Animal Products, Including Pork and Liver Products

In industrialized countries, most sporadic cases of hepatitis E infection occur after the ingestion of contaminated meat. Domestic pigs and wild boars are recognized as the primary animal reservoirs of HEV worldwide. Epidemics of HEV have been reported in Europe, particularly in France and Spain, where cases of infection were directly and respectively associated with the consumption of spit-roasted piglets and wild boar [144,145]. Along with the species mentioned above, others are known to be reservoirs carrying hepatitis E virus, including domestic and wild ruminants [146,147]. Anti-HEV antibodies have been detected in other animals, including deer, moose, rats, dogs, cats, camels, mongooses, cows, sheep, goats, avian species, rabbits, bats, and horses. Transmission from animals to humans is also documented through direct and indirect evidence in many countries [14,146,147,148,149,150,151].
HEV infection in pigs typically occurs early in life, with peak virus shedding occurring around 3 months of age. In pigs, HEV infection is asymptomatic, short-lived, and rapidly resolves. Indeed, HEV prevalence in pigs varies with age [152]. Among others, a study conducted in pigs in the United Kingdom revealed that the mean prevalence of HEV in pigs aged 3–5 weeks, 10–12 weeks, and 22–24 weeks and in dry adult sows was 26.0%, 44.0%, 8.9%, and 6.0%, respectively [31]. Beyond 12 weeks of life, viremia gradually decreases, showing the importance of considering the slaughter age of pigs.
Several concordant studies across the world have reported the presence of HEV in pigs, suggesting the existence of a zoonotic reservoir and evidence of foodborne transmission [70,126,153,154,155]. In Africa, a review conducted in 2020 by Bagulo et al. has reported high HEV seroprevalence in pigs, ranging from 47 to 80% [12,156,157,158,159,160]. More recently, in Sierra Leona, a low prevalence of HEV in pig sera of 4% (44 out of 1086) was documented, and the circulating strain belonged to genotype 3 [161]. However, a high prevalence of 47.7% of HEV antibodies and 36.1% of HEV-RNA in pigs was obtained, respectively, in Cameroon in 2020 and in the Central African Republic in 2024, still underlining the major circulation of HEV-3 strains in the swine population [162,163].
Pork and pork liver products are the most obvious sources of foodborne HEV and have been extensively studied in Europe. HEV has been detected in pig liver products sold in France, particularly in dried salted pig liver and figatelli, with a reported prevalence of 3% and 30%, respectively [164]. In America, authors have also reported the prevalence of HEV in pork liver products purchased from Ottawa grocery stores, with 10.5% and 47%, respectively, in pork livers and pork pâtés [165]. Few studies have reported HEV as a foodborne pathogen in Africa, mainly in pork products. Therefore, this virus was detected in 2/144 pork liver samples from South Africa in 2014 [166]. Recently, in Senegal, the first study reported the detection of HEV-RNA in pork meat and liver sold in Saint-Louis with a global prevalence of 5.4% with the following positivity rates: 3.1% and 22.2%, respectively, for meat and pork liver [155].
The high prevalence of HEV in pigs’ livers is interpreted as evidence based on the fact that the liver is the organ in which hepatitis E virus carries out its replication cycle [155,167]. The risk of contamination is lower for meat consumption. Still, it remains an important route through which sporadic cases of hepatitis E infection can occur in both developed and developing countries.
Regarding rat HEV, besides the suggested evidence of direct contact with rats or rat droppings, its foodborne transmission has not yet been investigated or reported [115]. Further studies are needed to address this question for a proper and detailed comprehension of their spreading and zoonotic transmission pathway.

5.3. HEV in Blood Products (Or Among Blood Donors)

Besides cases of the waterborne and zoonotic transmission of HEV, several authors have reported cases of transfusion-transmitted HEV, with a constant increase [39]. Cases of acute infection are self-limited in immunocompetent individuals. HEV infection often causes asymptomatic viremia in these individuals and can, therefore, be transmitted to humans via blood transfusion through the symbolic elements of the donor’s blood. Thus, the risk of infection by transfusion is associated with viremia in asymptomatic donors. In the case of HEV, the viremic period is estimated to be up to 88 days [168,169]. However, the probability of developing hepatitis E infection is strongly correlated with the donor’s viral load. In their systematic review, Dreier et al. reported that all components with a viral load > 5.00 × 104 UI cause hepatitis E infection, and this is independent of the recipient’s immune status [170,171].
Transmission through blood donation was also documented, with annual observations increasing, representing more than 2.5% of all transmissions [172]. However, it is essential to emphasize that blood transfusions are administered to patients only. The first transfusion-transmitted HEV infection (TT-HEV) was reported in Hokkaido, Japan, in 2004 [173]. Since this first report, more cases have been reported in Japan [174,175], France [36,176,177,178], the UK [34,41], Germany [179], and Spain [180,181]. In all cases, the HEV genomic sequences of the donor and the recipient patient were perfectly similar, confirming the possibility of the transmission of HEV by transfusion.
In several countries, cases of transmission by transfusion are often not reported, not because they do not exist but because they are not systematically diagnosed during blood donation. This could cause severe and chronic infections in immunocompromised recipients or those with certain vulnerabilities. Indeed, it has been reported that an estimated 60% of cases of HEV-infected immunocompromised patients develop chronic hepatitis E [182].
For this reason, some European countries and Japan have introduced screening for HEV RNA in blood donors using a universal screening method for all donors (used in Ireland, the UK and the Netherlands) and a selective screening method (used in France, Austria and Luxembourg), which consists of selecting from blood banks only those products intended for individuals considered to be at a high risk of developing complications linked to transfusion-transmitted HEV infection [171,180]. Analytic approaches such as the mini-pool nucleic acid test (MP-NAT) and individual donation nucleic acid test (ID -NAT) are two possible protocols used for screening HEV in blood supplies; thus, practices vary widely across laboratories worldwide. The latter is more sensitive but more expensive than the MP-NAT, making it challenging to use the ID-NAT in large-scale HEV screening programs [169,180].
More generally, these screening methods are often not systematically applied in emerging and developing countries due to a significant lack of resources. This increases the risk of the recurrence of chronic HEV infections, mainly in immunocompromised individuals, including HIV-infected persons, patients with rheumatologic disorders, and patients with haematologic malignancy [61].
In most African countries, blood donors are routinely tested only for HIV and hepatitis B and C, not for other emerging or unknown pathogens that could potentially threaten blood safety [157,183]. Due to dietary habits and other factors, all blood donors are exposed to HEV. The regular consumption of pork meat and shellfish was also reported in the viremic donors in China [39,184].
Worldwide, HEV immunomarkers have been investigated among blood donors. Anti-HEV IgG was found in this population group, with seroprevalences ranging from 2% (Fiji) to 43.5% (Poland). Between 1996 and 2018, anti-HEV IgM seroprevalences ranged from 0.2% in India to 49% in Italy [180]. In the same way, HEV RNA was detected among blood donors between 2004 and 2018, and reported positivity rates ranged from 0 to 1:27 (3.7%) in 2004 in Indian blood samples obtained from asymptomatic donors. After sequencing all HEV RNA-positive samples, it was concluded that the HEV-1 genotype was the causal agent of HEV transfusion-associated infections in that study [180,185].
A review of HEV in sub-Saharan Africa reported an overall seroprevalence among blood donors ranging from 0 to 49% and seroprevalences of 4.6 to 47.8% and 3.1 to 5.9% for IgG and IgM, respectively, showing the risk of contamination associated with blood donations [157,160,183,186,187,188,189,190,191].
Given that the serological prevalence of HEV is increasing worldwide and that severe cases can occur in recipients of donated blood, screening blood donations for HEV can help to mitigate the risk of transmission and protect vulnerable groups who are more likely to develop chronic forms of hepatitis E disease.

6. Environmental-Human–Animal Health Interconnections: One Health Perspective

As described in the previous sections, HEV is capable of surviving and/or persisting in different environments and different forms. In addition, its potential to cross the species barrier means that it has a wide host range, including humans and various animal species, thus revealing its zoonotic potential.
Under the prism of the “one health” concept, it is important to summarize the transmission pathways in a coordinated and comprehensive approach to take a global view of the various entities involved in the interactions.
Human or animal faeces containing HEV contaminate the environment. During flood episodes and to avoid possible overflows, water is often discharged into drainage systems, carrying any viral pathogens that may be present [124]. As a result, contaminated wastewater from sewage joins watercourses and aquatic environments and then contributes to the spread of microbial contaminants into the environment. It has been evidenced that sewage can contaminate drinking water sources, thus compromising consumer health and highlighting the risk of infection [192].
On the other hand, the detection of zoonotic HEV in surface and drinking water indicates the potential spreading of HEV-3 through water transmission [193,194,195]. Moreover, surface waters can be contaminated near pig production facilities, mainly due to run-off waters and percolation events or following the agronomic use of pig slurry [57,196,197]. Farm or abattoir run-off, combined sewer overflows, and inadequately treated sewage could be polluting watercourses with HEV [124], therefore offering evidence of thew spreading of the zoonotic genotypes through the environment. Usually, these genotypes are found in animal products. Thus, their detection in water suggests contamination by animal faeces or run-off from domestic farms. Similarly, the species present in the corresponding environments are likely to be contaminated. The persistence of hepatic and enteric viruses in the environment is evidence of their presence in irrigation water, compromising the safety of horticultural products and the consumer’s health [198].
Occupationally exposed humans, including those working in slaughterhouses, forestry workers, hunters, farmers, or veterinarians, have higher HEV and are exposed in various ways to hepatitis E virus, especially as they are often in contact with animals, sewage, and faeces, among other aspects. This provides evidence for zoonotic transmission from animals to humans through direct/indirect contact with animal reservoirs, which also constitutes a high risk of exposure to HEV [148,199]. To control and manage this risk of exposure, it is crucial to pay close attention to hygiene measures and the correct and systematic use of personal protective equipment. In addition, implementing suitable measures for the proper management of animal waste (including wastewater) from farms should be considered.
From the one health perspective, surveillance is necessary to prevent HEV infection and control its emergence or re-emergence in some regions, such as sub-Saharan countries. This approach aims to be collaborative, holistic, and multidisciplinary, guaranteeing and improving human, animal, and environmental health by limiting the global spread of HEV.

7. Conclusions

This review provides an overview of current knowledge about HEV and traces the various routes of transmission known to date. The prevalence reported in different matrices (food and environmental samples) and among blood donors highlights the different risk factors for exposure to hepatitis E virus, as well as its circulation within different entities. A substantial part of the population is exposed to HEV through dietary habits, particularly undercooked or uncooked meat products, including shellfish, pork, and pork liver products. Rats, small ruminants and other livestock are also not negligible reservoirs of HEV. In addition, sanitation workers, slaughterhouse workers, and farmers are also at risk of contracting HEV infection. Beyond the fact that HEV is an emerging pathogen with global distribution and should receive more attention from public health authorities, it remains a virus that has been very little studied in Africa. Consequently, large-scale studies should be addressed to further document the genotypes circulating in the continent and understand their interactions with hosts, including those potentially released into the environment, in order to prevent and monitor their spread.

Author Contributions

S.D.T.: writing—original draft preparation, writing—review and editing, methodology, data curation, software, formal analysis; A.A.M.D.: conceptualization, funding acquisition, methodology, data curation, software, writing—review and editing, supervision and validation; S.S.: methodology, writing—review and editing, visualization; S.C.: methodology, writing—review and editing, visualization. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the International Development Research Centre (IDRC) and the Ministry of Higher Education, Research and Innovation (MESRI) of Senegal, which contributed to the funding of the project “Molecular epidemiology of the hepatitis E virus using a one health approach” through FIRST as part of the SGCI2 funding program.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).

Acknowledgments

We are grateful to the top management of the Ecole Supérieure Polytechnique (ESP) for their support of the GRBA-BE team.

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.

References

  1. WHO. Hepatitis E. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e (accessed on 8 November 2023).
  2. Rein, D.B.; Stevens, G.A.; Theaker, J.; Wittenborn, J.S.; Wiersma, S.T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012, 55, 988. [Google Scholar] [CrossRef]
  3. Kamar, N.; Bendall, R.; Legrand-Abravanel, F.; Xia, N.-S.; Ijaz, S.; Izopet, J.; Dalton, H.R. Hepatitis E. Lancet 2012, 379, 2477–2488. [Google Scholar] [CrossRef] [PubMed]
  4. Purcell, R.H.; Emerson, S.U. Hepatitis E: An emerging awareness of an old disease. J. Hepatol. 2008, 48, 494–503. [Google Scholar] [CrossRef] [PubMed]
  5. World Health Assembly. Viral Hepatitis: Report by the Secretariat. 2010. Available online: https://iris.who.int/handle/10665/2383 (accessed on 8 November 2023).
  6. Béji-Hamza, A.; Hassine-Zaafrane, M.; Khélifi-Gharbi, H.; Della Libera, S.; Iaconelli, M.; Muscillo, M.; Petricca, S.; Ciccaglione, A.R.; Bruni, R.; Taffon, S.; et al. Hepatitis E virus genotypes 1 and 3 in wastewater samples in Tunisia. Arch. Virol. 2015, 160, 183–189. [Google Scholar] [CrossRef] [PubMed]
  7. Purdy, M.A.; Drexler, J.F.; Meng, X.-J.; Norder, H.; Okamoto, H.; Van der Poel, W.H.M.; Reuter, G.; de Souza, W.M.; Ulrich, R.G.; Smith, D.B. ICTV Virus Taxonomy Profile: Hepeviridae 2022. J. Gen. Virol. 2022, 103, 001778. [Google Scholar] [CrossRef]
  8. International Committee on Taxonomy of Viruses (ICTV). Current ICTV Taxonomy Release. Available online: https://ictv.global/taxonomy (accessed on 7 September 2024).
  9. Priemer, G.; Cierniak, F.; Wolf, C.; Ulrich, R.G.; Groschup, M.H.; Eiden, M. Co-Circulation of Different Hepatitis E Virus Genotype 3 Subtypes in Pigs and Wild Boar in North-East Germany, 2019. Pathogens 2022, 11, 773. [Google Scholar] [CrossRef]
  10. Aggarwal, R. Hepatitis e: Epidemiology and natural history. J. Clin. Exp. Hepatol. 2013, 3, 125–133. [Google Scholar] [CrossRef]
  11. Hakim, M.S.; Wang, W.; Bramer, W.M.; Geng, J.; Huang, F.; de Man, R.A.; Peppelenbosch, M.P.; Pan, Q. The global burden of hepatitis E outbreaks: A systematic review. Liver Int. 2017, 37, 19–31. [Google Scholar] [CrossRef]
  12. Majekodunmi, A.O.; Addo, H.O.; Bagulo, H.; Bimi, L. Integrated value-chain and risk assessment of Pig-Related Zoonoses in Ghana. PLoS ONE 2019, 14, e0224918. [Google Scholar] [CrossRef]
  13. Yugo, D.M.; Meng, X.-J. Hepatitis E Virus: Foodborne, Waterborne and Zoonotic Transmission. Int. J. Environ. Res. Public Health 2013, 10, 4507–4533. [Google Scholar] [CrossRef]
  14. Khuroo, M.S.; Khuroo, M.S.; Khuroo, N.S. Transmission of Hepatitis E Virus in Developing Countries. Viruses 2016, 8, 253. [Google Scholar] [CrossRef]
  15. Singh, M.P.; Majumdar, M.; Goyal, K.; Lakshmi, P.V.M.; Bhatia, D.; Ratho, R.K. Investigation of suspected viral hepatitis outbreaks in North West India. Diagn. Microbiol. Infect. Dis. 2016, 84, 309–314. [Google Scholar] [CrossRef] [PubMed]
  16. Zahmanova, G.; Takova, K.; Tonova, V.; Koynarski, T.; Lukov, L.L.; Minkov, I.; Pishmisheva, M.; Kotsev, S.; Tsachev, I.; Baymakova, M.; et al. The Re-Emergence of Hepatitis E Virus in Europe and Vaccine Development. Viruses 2023, 15, 1558. [Google Scholar] [CrossRef] [PubMed]
  17. Doceul, V.; Bagdassarian, E.; Demange, A.; Pavio, N. Zoonotic Hepatitis E Virus: Classification, Animal Reservoirs and Transmission Routes. Viruses 2016, 8, 270. [Google Scholar] [CrossRef]
  18. Izopet, J.; Tremeaux, P.; Marion, O.; Migueres, M.; Capelli, N.; Chapuy-Regaud, S.; Mansuy, J.-M.; Abravanel, F.; Kamar, N.; Lhomme, S. Hepatitis E virus infections in Europe. J. Clin. Virol. 2019, 120, 20–26. [Google Scholar] [CrossRef] [PubMed]
  19. Colson, P.; Borentain, P.; Queyriaux, B.; Kaba, M.; Moal, V.; Gallian, P.; Heyries, L.; Raoult, D.; Gerolami, R. Pig liver sausage as a source of hepatitis E virus transmission to humans. J. Infect. Dis. 2010, 202, 825–834. [Google Scholar] [CrossRef]
  20. Yazaki, Y.; Mizuo, H.; Takahashi, M.; Nishizawa, T.; Sasaki, N.; Gotanda, Y.; Okamoto, H. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food. J. Gen. Virol. 2003, 84, 2351–2357. [Google Scholar] [CrossRef]
  21. Smith, D.B.; Simmonds, P.; Izopet, J.; Oliveira-Filho, E.F.; Ulrich, R.G.; Johne, R.; Koenig, M.; Jameel, S.; Harrison, T.J.; Meng, X.-J.; et al. Proposed reference sequences for hepatitis E virus subtypes. J. Gen. Virol. 2016, 97, 537–542. [Google Scholar] [CrossRef]
  22. Woo, P.C.Y.; Lau, S.K.P.; Teng, J.L.L.; Cao, K.-Y.; Wernery, U.; Schountz, T.; Chiu, T.H.; Tsang, A.K.L.; Wong, P.-C.; Wong, E.Y.M.; et al. New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013. Emerg. Infect. Dis. 2016, 22, 2219–2221. [Google Scholar] [CrossRef]
  23. Lee, G.-H.; Tan, B.-H.; Chi-Yuan Teo, E.; Lim, S.-G.; Dan, Y.-Y.; Wee, A.; Kim Aw, P.P.; Zhu, Y.; Hibberd, M.L.; Tan, C.-K.; et al. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk. Gastroenterology 2016, 150, 355–357.e3. [Google Scholar] [CrossRef]
  24. Casares-Jimenez, M.; Rivero-Juarez, A.; Lopez-Lopez, P.; Montes, M.L.; Navarro-Soler, R.; Peraire, J.; Espinosa, N.; Alemán-Valls, M.R.; Garcia-Garcia, T.; Caballero-Gomez, J.; et al. Rat hepatitis E virus (Rocahepevirus ratti) in people living with HIV. Emerg. Microbes Infect. 2023, 13, 2295389. [Google Scholar] [CrossRef]
  25. Reuter, G.; Boros, Á.; Pankovics, P. Review of Hepatitis E Virus in Rats: Evident Risk of Species Orthohepevirus C to Human Zoonotic Infection and Disease. Viruses 2020, 12, 1148. [Google Scholar] [CrossRef] [PubMed]
  26. Situ, J.; Lo, K.H.-Y.; Cai, J.-P.; Li, Z.; Wu, S.; Shun, E.H.-K.; Chew, N.F.-S.; Tsoi, J.Y.-H.; Chan, G.S.-M.; Chan, W.H.-M.; et al. An immunoassay system to investigate epidemiology of Rocahepevirus ratti (rat hepatitis E virus) infection in humans. JHEP Rep. 2023, 5, 100793. [Google Scholar] [CrossRef] [PubMed]
  27. Sridhar, S.; Yip, C.C.; Wu, S.; Chew, N.F.; Leung, K.; Chan, J.F.; Zhao, P.S.; Chan, W.; Poon, R.W.; Tsoi, H.; et al. Transmission of Rat Hepatitis E Virus Infection to Humans in Hong Kong: A Clinical and Epidemiological Analysis. Hepatology 2021, 73, 10–22. [Google Scholar] [CrossRef] [PubMed]
  28. Sridhar, S.; Yip, C.C.Y.; Lo, K.H.Y.; Wu, S.; Situ, J.; Chew, N.F.S.; Leung, K.H.; Chan, H.S.Y.; Wong, S.C.Y.; Leung, A.W.S.; et al. Hepatitis E Virus Species C Infection in Humans, Hong Kong. Clin. Infect. Dis. 2021, 75, 288–296. [Google Scholar] [CrossRef]
  29. Wang, B.; Harms, D.; Yang, X.-L.; Bock, C.-T. Orthohepevirus C: An Expanding Species of Emerging Hepatitis E Virus Variants. Pathogens 2020, 9, 154. [Google Scholar] [CrossRef]
  30. Meng, X.-J. Zoonotic and foodborne transmission of hepatitis E virus. Semin. Liver Dis. 2013, 33, 41–49. [Google Scholar] [CrossRef]
  31. McCreary, C.; Martelli, F.; Grierson, S.; Ostanello, F.; Nevel, A.; Banks, M. Excretion of hepatitis E virus by pigs of different ages and its presence in slurry stores in the United Kingdom. Vet. Rec. 2008, 163, 261–265. [Google Scholar] [CrossRef]
  32. Kokkinos, P.; Kozyra, I.; Lazic, S.; Bouwknegt, M.; Rutjes, S.; Willems, K.; Moloney, R.; de Roda Husman, A.M.; Kaupke, A.; Legaki, E.; et al. Harmonised investigation of the occurrence of human enteric viruses in the leafy green vegetable supply chain in three European countries. Food Environ. Virol. 2012, 4, 179–191. [Google Scholar] [CrossRef]
  33. Crossan, C.; Baker, P.J.; Craft, J.; Takeuchi, Y.; Dalton, H.R.; Scobie, L. Hepatitis E Virus Genotype 3 in Shellfish, United Kingdom. Emerg. Infect. Dis. 2012, 18, 2085–2087. [Google Scholar] [CrossRef]
  34. Boxall, E.; Herborn, A.; Kochethu, G.; Pratt, G.; Adams, D.; Ijaz, S.; Teo, C.-G. Transfusion-transmitted hepatitis E in a “nonhyperendemic” country. Transfus. Med. 2006, 16, 79–83. [Google Scholar] [CrossRef]
  35. Fontana, S.; Ripellino, P.; Niederhauser, C.; Widmer, N.; Gowland, P.; Petrini, O.; Aprile, M.; Merlani, G.; Bihl, F. Epidemiology of HEV Infection in Blood Donors in Southern Switzerland. Microorganisms 2023, 11, 2375. [Google Scholar] [CrossRef] [PubMed]
  36. Gallian, P.; Pouchol, E.; Djoudi, R.; Lhomme, S.; Mouna, L.; Gross, S.; Bierling, P.; Assal, A.; Kamar, N.; Mallet, V.; et al. Transfusion-Transmitted Hepatitis E Virus Infection in France. Transfus. Med. Rev. 2019, 33, 146–153. [Google Scholar] [CrossRef] [PubMed]
  37. Kamar, N.; Selves, J.; Mansuy, J.-M.; Ouezzani, L.; Péron, J.-M.; Guitard, J.; Cointault, O.; Esposito, L.; Abravanel, F.; Danjoux, M.; et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N. Engl. J. Med. 2008, 358, 811–817. [Google Scholar] [CrossRef] [PubMed]
  38. Lhomme, S.; Bardiaux, L.; Abravanel, F.; Gallian, P.; Kamar, N.; Izopet, J. Hepatitis E Virus Infection in Solid Organ Transplant Recipients, France. Emerg. Infect. Dis. 2017, 23, 353–356. [Google Scholar] [CrossRef]
  39. Cheung, C.K.M.; Wong, S.H.; Law, A.W.H.; Law, M.F. Transfusion-transmitted hepatitis E: What we know so far? World J. Gastroenterol. 2022, 28, 47–75. [Google Scholar] [CrossRef]
  40. Vollmer, T.; Diekmann, J.; Johne, R.; Eberhardt, M.; Knabbe, C.; Dreier, J. Novel approach for detection of hepatitis E virus infection in German blood donors. J. Clin. Microbiol. 2012, 50, 2708–2713. [Google Scholar] [CrossRef]
  41. Hewitt, P.E.; Ijaz, S.; Brailsford, S.R.; Brett, R.; Dicks, S.; Haywood, B.; Kennedy, I.T.R.; Kitchen, A.; Patel, P.; Poh, J.; et al. Hepatitis E virus in blood components: A prevalence and transmission study in southeast England. Lancet 2014, 384, 1766–1773. [Google Scholar] [CrossRef]
  42. Domanović, D.; Tedder, R.; Blümel, J.; Zaaijer, H.; Gallian, P.; Niederhauser, C.; Sauleda Oliveras, S.; O’Riordan, J.; Boland, F.; Harritshøj, L.; et al. Hepatitis E and blood donation safety in selected European countries: A shift to screening? Euro Surveill. 2017, 22, 30514. [Google Scholar] [CrossRef]
  43. Boland, F.; Martinez, A.; Pomeroy, L.; O’Flaherty, N. Blood Donor Screening for Hepatitis E Virus in the European Union. Transfus. Med. Hemother 2019, 46, 95–103. [Google Scholar] [CrossRef]
  44. Aggarwal, R. Hepatitis E: Historical, contemporary and future perspectives. J. Gastroenterol. Hepatol. 2011, 26 (Suppl. S1), 72–82. [Google Scholar] [CrossRef]
  45. Diouara, A.A.M.; Lo, S.; Nguer, C.M.; Senghor, A.; Diop Ndiaye, H.; Manga, N.M.; Danfakha, F.; Diallo, S.; Faye Dieme, M.E.; Thiam, O.; et al. Hepatitis E Virus Seroprevalence and Associated Risk Factors in Pregnant Women Attending Antenatal Consultations in Senegal. Viruses 2022, 14, 1742. [Google Scholar] [CrossRef]
  46. Lhomme, S.; Abravanel, F.; Dubois, M.; Sandres-Saune, K.; Mansuy, J.-M.; Rostaing, L.; Kamar, N.; Izopet, J. Characterization of the Polyproline Region of the Hepatitis E Virus in Immunocompromised Patients. J. Virol. 2014, 88, 12017–12025. [Google Scholar] [CrossRef]
  47. WHO. The Global Prevalence of Hepatitis E Virus Infection and Susceptibility. Available online: https://www.who.int/publications-detail-redirect/WHO-IVB-10.14 (accessed on 8 November 2023).
  48. Crum-Cianflone, N.F.; Curry, J.; Drobeniuc, J.; Weintrob, A.; Landrum, M.; Ganesan, A.; Bradley, W.; Agan, B.K.; Kamili, S. Hepatitis E Virus Infection in HIV-infected Persons. Emerg. Infect. Dis. 2012, 18, 502–506. [Google Scholar] [CrossRef]
  49. Karna, R.; Hazam, R.K.; Borkakoti, J.; Kumar, A.; Kar, P. A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy. J. Clin. Exp. Hepatol. 2020, 10, 135–138. [Google Scholar] [CrossRef]
  50. Khuroo, M.S.; Kamili, S.; Khuroo, M.S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J. Viral Hepat. 2009, 16, 519–523. [Google Scholar] [CrossRef] [PubMed]
  51. Pischke, S.; Hartl, J.; Pas, S.D.; Lohse, A.W.; Jacobs, B.C.; Van der Eijk, A.A. Hepatitis E virus: Infection beyond the liver? J. Hepatol. 2017, 66, 1082–1095. [Google Scholar] [CrossRef]
  52. Wu, C.; Wu, X.; Xia, J. Hepatitis E virus infection during pregnancy. Virol. J. 2020, 17, 73. [Google Scholar] [CrossRef] [PubMed]
  53. Geng, Y.; Wang, Y. Epidemiology of Hepatitis E. Adv. Exp. Med. Biol. 2016, 948, 39–59. [Google Scholar] [CrossRef] [PubMed]
  54. Kim, J.-H.; Nelson, K.E.; Panzner, U.; Kasture, Y.; Labrique, A.B.; Wierzba, T.F. A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect. Dis. 2014, 14, 308. [Google Scholar] [CrossRef]
  55. Africa CDC. Hepatitis E Virus. Available online: https://africacdc.org/disease/hepatitis-e-virus/ (accessed on 8 November 2023).
  56. Modiyinji, A.F.; Bigna, J.J.; Kenmoe, S.; Simo, F.B.N.; Amougou, M.A.; Ndangang, M.S.; Nola, M.; Njouom, R. Epidemiology of hepatitis E virus infection in animals in Africa: A systematic review and meta-analysis. BMC Vet. Res. 2021, 17, 50. [Google Scholar] [CrossRef]
  57. Takuissu, G.R.; Kenmoe, S.; Ndip, L.; Ebogo-Belobo, J.T.; Kengne-Ndé, C.; Mbaga, D.S.; Bowo-Ngandji, A.; Oyono, M.G.; Kenfack-Momo, R.; Tchatchouang, S.; et al. Hepatitis E Virus in Water Environments: A Systematic Review and Meta-analysis. Food Environ. Virol. 2022, 14, 223–235. [Google Scholar] [CrossRef] [PubMed]
  58. Di Profio, F.; Sarchese, V.; Palombieri, A.; Fruci, P.; Lanave, G.; Robetto, S.; Martella, V.; Di Martino, B. Current Knowledge of Hepatitis E Virus (HEV) Epidemiology in Ruminants. Pathogens 2022, 11, 1124. [Google Scholar] [CrossRef] [PubMed]
  59. Nair, V.P.; Anang, S.; Subramani, C.; Madhvi, A.; Bakshi, K.; Srivastava, A.; Shalimar; Nayak, B.; Kumar, R.C.T.; Surjit, M. Endoplasmic Reticulum Stress Induced Synthesis of a Novel Viral Factor Mediates Efficient Replication of Genotype-1 Hepatitis E Virus. PLoS Pathog. 2016, 12, e1005521. [Google Scholar] [CrossRef] [PubMed]
  60. Sheng, Y.; Deng, Y.; Li, X.; Ji, P.; Sun, X.; Liu, B.; Zhu, J.; Zhao, J.; Nan, Y.; Zhou, E.-M.; et al. Hepatitis E virus ORF3 protein hijacking thioredoxin domain-containing protein 5 (TXNDC5) for its stability to promote viral particle release. J. Virol. 2024, 98, e01649-23. [Google Scholar] [CrossRef]
  61. Songtanin, B.; Molehin, A.J.; Brittan, K.; Manatsathit, W.; Nugent, K. Hepatitis E Virus Infections: Epidemiology, Genetic Diversity, and Clinical Considerations. Viruses 2023, 15, 1389. [Google Scholar] [CrossRef]
  62. Gouttenoire, J.; Pollán, A.; Abrami, L.; Oechslin, N.; Mauron, J.; Matter, M.; Oppliger, J.; Szkolnicka, D.; Thi, V.L.D.; Goot, F.G.v.d.; et al. Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion. PLoS Pathog. 2018, 14, e1007471. [Google Scholar] [CrossRef]
  63. Zafrullah, M.; Ozdener, M.H.; Panda, S.K.; Jameel, S. The ORF3 protein of hepatitis E virus is a phosphoprotein that associates with the cytoskeleton. J. Virol. 1997, 71, 9045–9053. [Google Scholar] [CrossRef]
  64. Cao, D.; Meng, X.-J. Molecular biology and replication of hepatitis E virus. Emerg. Microbes Infect. 2012, 1, 1–10. [Google Scholar] [CrossRef]
  65. Jothikumar, N.; Cromeans, T.L.; Robertson, B.H.; Meng, X.J.; Hill, V.R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 2006, 131, 65–71. [Google Scholar] [CrossRef]
  66. Vina-Rodriguez, A.; Schlosser, J.; Becher, D.; Kaden, V.; Groschup, M.H.; Eiden, M. Hepatitis E Virus Genotype 3 Diversity: Phylogenetic Analysis and Presence of Subtype 3b in Wild Boar in Europe. Viruses 2015, 7, 2704–2726. [Google Scholar] [CrossRef]
  67. Nagashima, S.; Takahashi, M.; Kobayashi, T.; Tanggis; Nishizawa, T.; Nishiyama, T.; Primadharsini, P.P.; Okamoto, H. Characterization of the Quasi-Enveloped Hepatitis E Virus Particles Released by the Cellular Exosomal Pathway. Available online: https://journals.asm.org/doi/epub/10.1128/jvi.00822-17 (accessed on 10 November 2023).
  68. Shahini, E.; Argentiero, A.; Andriano, A.; Losito, F.; Maida, M.; Facciorusso, A.; Cozzolongo, R.; Villa, E. Hepatitis E Virus: What More Do We Need to Know? Medicina 2024, 60, 998. [Google Scholar] [CrossRef]
  69. La Bella, G.; Basanisi, M.G.; Nobili, G.; Coppola, R.; Damato, A.M.; Donatiello, A.; Occhiochiuso, G.; Romano, A.C.; Toce, M.; Palazzo, L.; et al. Evidence of Circulation and Phylogenetic Analysis of Hepatitis E Virus (HEV) in Wild Boar in South-East Italy. Viruses 2023, 15, 2021. [Google Scholar] [CrossRef]
  70. Locus, T.; Lambrecht, E.; Peeters, M.; Suin, V.; Verhaegen, B.; Van Hoorde, K.; Lamoral, S.; Vanwolleghem, T.; Van Gucht, S. Hepatitis E virus in pork meat products and exposure assessment in Belgium. Int. J. Food Microbiol. 2023, 397, 110198. [Google Scholar] [CrossRef]
  71. Smith, D.B.; Izopet, J.; Nicot, F.; Simmonds, P.; Jameel, S.; Meng, X.-J.; Norder, H.; Okamoto, H.; van der Poel, W.H.M.; Reuter, G.; et al. Update: Proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J. Gen. Virol. 2020, 101, 692–698. [Google Scholar] [CrossRef]
  72. Sarani, A.; Ravanbakhsh, A.; Kamaladini, H. First detection of hepatitis E virus in dromedary camels from Iran. Vet. Med. Sci. 2023, 9, 1812–1817. [Google Scholar] [CrossRef]
  73. Carella, E.; Oberto, F.; Romano, A.; Peletto, S.; Vitale, N.; Costa, A.; Caruso, C.; Chiavacci, L.; Acutis, P.L.; Pite, L.; et al. Molecular and serological investigation of Hepatitis E virus in pigs slaughtered in Northwestern Italy. BMC Vet. Res. 2023, 19, 21. [Google Scholar] [CrossRef]
  74. Miao, Z.; Cao, K.; Wu, X.; Zhang, C.; Gao, J.; Chen, Y.; Sun, Z.; Ren, X.; Chen, Y.; Yang, M.; et al. An outbreak of hepatitis E virus genotype 4d caused by consuming undercooked pig liver in a nursing home in Zhejiang Province, China. Int. J. Food Microbiol. 2024, 417, 110682. [Google Scholar] [CrossRef] [PubMed]
  75. Said, B.; Ijaz, S.; Kafatos, G.; Booth, L.; Thomas, H.L.; Walsh, A.; Ramsay, M.; Morgan, D. Hepatitis E Outbreak on Cruise Ship. Emerg. Infect. Dis. 2009, 15, 1738–1744. [Google Scholar] [CrossRef] [PubMed]
  76. Yapa, C.M.; Furlong, C.; Rosewell, A.; Ward, K.A.; Adamson, S.; Shadbolt, C.; Kok, J.; Tracy, S.L.; Bowden, S.; Smedley, E.J.; et al. First reported outbreak of locally acquired hepatitis E virus infection in Australia. Med. J. Aust. 2016, 204, 274. [Google Scholar] [CrossRef] [PubMed]
  77. Yin, W.; Han, Y.; Xin, H.; Liu, W.; Song, Q.; Li, Z.; Gao, S.; Jiang, F.; Cao, J.; Bi, S.; et al. Hepatitis E outbreak in a mechanical factory in Qingdao City, China. Int. J. Infect. Dis. IJID Off. Publ. Int. Soc. Infect. Dis. 2019, 86, 191–196. [Google Scholar] [CrossRef]
  78. Zhang, L.; Yan, B.; Xu, A. A hepatitis E outbreak by genotype 4 virus in Shandong province, China. Vaccine 2016, 34, 3715–3718. [Google Scholar] [CrossRef]
  79. Crotta, M.; Pellicioli, L.; Gaffuri, A.; Trogu, T.; Formenti, N.; Tranquillo, V.; Luzzago, C.; Ferrari, N.; Lanfranchi, P. Analysis of seroprevalence data on Hepatitis E virus and Toxoplasma gondii in wild ungulates for the assessment of human exposure to zoonotic meat-borne pathogens. Food Microbiol. 2022, 101, 103890. [Google Scholar] [CrossRef] [PubMed]
  80. Ianiro, G.; Chelli, E.; De Sabato, L.; Monini, M.; Ostanello, F.; Di Bartolo, I. Long-term surveillance for hepatitis E virus in an Italian two-site farrow-to-finish swine farm. Zoonoses Public Health 2021, 68, 474–482. [Google Scholar] [CrossRef] [PubMed]
  81. Li, T.-C.; Bai, H.; Yoshizaki, S.; Ami, Y.; Suzaki, Y.; Doan, Y.H.; Takahashi, K.; Mishiro, S.; Takeda, N.; Wakita, T. Genotype 5 Hepatitis E Virus Produced by a Reverse Genetics System Has the Potential for Zoonotic Infection. Hepatol. Commun. 2019, 3, 160–172. [Google Scholar] [CrossRef] [PubMed]
  82. Takahashi, M.; Nishizawa, T.; Nagashima, S.; Jirintai, S.; Kawakami, M.; Sonoda, Y.; Suzuki, T.; Yamamoto, S.; Shigemoto, K.; Ashida, K.; et al. Molecular characterization of a novel hepatitis E virus (HEV) strain obtained from a wild boar in Japan that is highly divergent from the previously recognized HEV strains. Virus Res. 2014, 180, 59–69. [Google Scholar] [CrossRef]
  83. Santos-Silva, S.; Hemnani, M.; Lopez-Lopez, P.; Gonçalves, H.M.R.; Rivero-Juarez, A.; Van der Poel, W.H.M.; Nascimento, M.S.J.; Mesquita, J.R. A Systematic Review of Hepatitis E Virus Detection in Camels. Vet. Sci. 2023, 10, 323. [Google Scholar] [CrossRef]
  84. Sridhar, S.; Teng, J.L.L.; Chiu, T.-H.; Lau, S.K.P.; Woo, P.C.Y. Hepatitis E Virus Genotypes and Evolution: Emergence of Camel Hepatitis E Variants. Int. J. Mol. Sci. 2017, 18, 869. [Google Scholar] [CrossRef]
  85. Cook, N.; D’Agostino, M.; Johne, R. Potential Approaches to Assess the Infectivity of Hepatitis E Virus in Pork Products: A Review. Food Environ. Virol. 2017, 9, 243–255. [Google Scholar] [CrossRef]
  86. Li, T.-C.; Zhou, X.; Yoshizaki, S.; Ami, Y.; Suzaki, Y.; Nakamura, T.; Takeda, N.; Wakita, T. Production of infectious dromedary camel hepatitis E virus by a reverse genetic system: Potential for zoonotic infection. J. Hepatol. 2016, 65, 1104–1111. [Google Scholar] [CrossRef]
  87. Smith, D.B.; Simmonds, P.; International Committee on Taxonomy of Viruses Hepeviridae Study Group; Jameel, S.; Emerson, S.U.; Harrison, T.J.; Meng, X.J.; Okamoto, H.; Van der Poel, W.H.; Purdy, M.A. Consensus proposals for classification of the family Hepeviridae. J. Gen. Virol. 2014, 95, 2223–2232. [Google Scholar] [CrossRef]
  88. Wang, B.; Meng, X.-J. Structural and molecular biology of hepatitis E virus. Comput. Struct. Biotechnol. J. 2021, 19, 1907–1916. [Google Scholar] [CrossRef]
  89. Wang, B.; Meng, X.-J. Hepatitis E virus: Host tropism and zoonotic infection. Curr. Opin. Microbiol. 2020, 59, 8–15. [Google Scholar] [CrossRef]
  90. Gouy, M.; Guindon, S.; Gascuel, O. SeaView Version 4: A Multiplatform Graphical User Interface for Sequence Alignment and Phylogenetic Tree Building. Mol. Biol. Evol. 2010, 27, 221–224. [Google Scholar] [CrossRef] [PubMed]
  91. Guindon, S.; Dufayard, J.-F.; Lefort, V.; Anisimova, M.; Hordijk, W.; Gascuel, O. New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0. Syst. Biol. 2010, 59, 307–321. [Google Scholar] [CrossRef] [PubMed]
  92. Kumar, S.; Stecher, G.; Li, M.; Knyaz, C.; Tamura, K. MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms. Mol. Biol. Evol. 2018, 35, 1547–1549. [Google Scholar] [CrossRef] [PubMed]
  93. Rambaut FigTree v. 1.4.4. ResearchGate. Available online: http://tree.bio.ed.ac.uk/software/figtree/ (accessed on 11 December 2023).
  94. Miagostovich, M.P.; Rocha, M.S.; dos Reis, F.B.; Sampaio, M.S.; de Saldanha da Gama Gracie Carrijo, R.; Malta, F.C.; Rodrigues, J.; Genuino, A.; Ribeiro da Silva Assis, M.; Fumian, T.M.; et al. Gastroenteric Viruses Detection in a Drinking Water Distribution-to-Consumption System in a Low-Income Community in Rio de Janeiro. Food Environ. Virol. 2020, 12, 130–136. [Google Scholar] [CrossRef]
  95. WHO. Drinking-Water. Available online: https://www.who.int/news-room/fact-sheets/detail/drinking-water (accessed on 3 May 2024).
  96. Cuevas-Ferrando, E.; Randazzo, W.; Pérez-Cataluña, A.; Sánchez, G. HEV Occurrence in Waste and Drinking Water Treatment Plants. Front. Microbiol. 2020, 10, 2937. [Google Scholar] [CrossRef]
  97. Orf, G.S.; Bbosa, N.; Berg, M.G.; Downing, R.; Weiss, S.L.; Ssemwanga, D.; Ssekagiri, A.; Ashraf, S.; da Silva Filipe, A.; Kiiza, R.; et al. The 2023 South Sudanese outbreak of Hepatitis E emphasizes ongoing circulation of genotype 1 in North, Central, and East Africa. Infect. Genet. Evol. 2024, 124, 105667. [Google Scholar] [CrossRef]
  98. Fenaux, H.; Chassaing, M.; Berger, S.; Gantzer, C.; Bertrand, I.; Schvoerer, E. Transmission of hepatitis E virus by water: An issue still pending in industrialized countries. Water Res. 2019, 151, 144–157. [Google Scholar] [CrossRef]
  99. Haramoto, E.; Kitajima, M.; Hata, A.; Torrey, J.R.; Masago, Y.; Sano, D.; Katayama, H. A review on recent progress in the detection methods and prevalence of human enteric viruses in water. Water Res. 2018, 135, 168–186. [Google Scholar] [CrossRef] [PubMed]
  100. Miura, T.; Lhomme, S.; Le Saux, J.-C.; Le Mehaute, P.; Guillois, Y.; Couturier, E.; Izopet, J.; Abranavel, F.; Le Guyader, F.S. Detection of Hepatitis E Virus in Sewage After an Outbreak on a French Island. Food Environ. Virol. 2016, 8, 194–199. [Google Scholar] [CrossRef]
  101. Chen, Y.J.; Cao, N.X.; Xie, R.H.; Ding, C.X.; Chen, E.F.; Zhu, H.P.; Sun, J.M.; Shang, X.P.; Wang, X.X.; Miao, Z.P. Epidemiological investigation of a tap water-mediated hepatitis E virus genotype 4 outbreak in Zhejiang Province, China. Epidemiol. Infect. 2016, 144, 3387–3399. [Google Scholar] [CrossRef]
  102. Nemes, K.; Persson, S.; Simonsson, M. Hepatitis A Virus and Hepatitis E Virus as Food- and Waterborne Pathogens-Transmission Routes and Methods for Detection in Food. Viruses 2023, 15, 1725. [Google Scholar] [CrossRef]
  103. Cancela, F.; Icasuriaga, R.; Cuevas, S.; Hergatacorzian, V.; Olivera, M.; Panzera, Y.; Pérez, R.; López, J.; Borzacconi, L.; González, E.; et al. Epidemiology Update of Hepatitis E Virus (HEV) in Uruguay: Subtyping, Environmental Surveillance and Zoonotic Transmission. Viruses 2023, 15, 2006. [Google Scholar] [CrossRef]
  104. Fong, T.-T.; Lipp, E.K. Enteric viruses of humans and animals in aquatic environments: Health risks, detection, and potential water quality assessment tools. Microbiol. Mol. Biol. Rev. 2005, 69, 357–371. [Google Scholar] [CrossRef]
  105. Purpari, G.; Macaluso, G.; Bella, S.D.; Gucciardi, F.; Mira, F.; Marco, P.D.; Lastra, A.; Petersen, E.; Rosa, G.L.; Guercio, A. Molecular characterization of human enteric viruses in food, water samples, and surface swabs in Sicily. Int. J. Infect. Dis. 2019, 80, 66–72. [Google Scholar] [CrossRef]
  106. Atmar, R.L.; Opekun, A.R.; Gilger, M.A.; Estes, M.K.; Crawford, S.E.; Neill, F.H.; Graham, D.Y. Norwalk Virus Shedding after Experimental Human Infection. Emerg. Infect. Dis. 2008, 14, 1553. [Google Scholar] [CrossRef]
  107. Johne, R.; Scholz, J.; Falkenhagen, A. Heat stability of foodborne viruses—Findings, methodological challenges and current developments. Int. J. Food Microbiol. 2024, 413, 110582. [Google Scholar] [CrossRef]
  108. Oza, H.H.; Lee, M.G.; Boisson, S.; Pega, F.; Medlicott, K.; Clasen, T. Occupational health outcomes among sanitation workers: A systematic review and meta-analysis. Int. J. Hyg. Environ. Health 2022, 240, 113907. [Google Scholar] [CrossRef]
  109. Di Profio, F.; Melegari, I.; Palombieri, A.; Sarchese, V.; Arbuatti, A.; Fruci, P.; Marsilio, F.; Martella, V.; Di Martino, B. High prevalence of hepatitis E virus in raw sewage in Southern Italy. Virus Res. 2019, 272, 197710. [Google Scholar] [CrossRef] [PubMed]
  110. Iaconelli, M.; Purpari, G.; Della Libera, S.; Petricca, S.; Guercio, A.; Ciccaglione, A.R.; Bruni, R.; Taffon, S.; Equestre, M.; Fratini, M.; et al. Hepatitis A and E Viruses in Wastewaters, in River Waters, and in Bivalve Molluscs in Italy. Food Environ. Virol. 2015, 7, 316–324. [Google Scholar] [CrossRef] [PubMed]
  111. Mesquita, J.R.; Oliveira, D.; Rivadulla, E.; Abreu-Silva, J.; Varela, M.F.; Romalde, J.L.; Nascimento, M.S.J. Hepatitis E virus genotype 3 in mussels (Mytilus galloprovinciallis), Spain. Food Microbiol. 2016, 58, 13–15. [Google Scholar] [CrossRef] [PubMed]
  112. Alzate, D.; Lopez-Osorio, M.C.; Cortés-Mancera, F.; Navas, M.-C.; Orozco, J. Detection of hepatitis E virus genotype 3 in wastewater by an electrochemical genosensor. Anal. Chim. Acta 2022, 1221, 340121. [Google Scholar] [CrossRef]
  113. Fatawou, M.A.; Chavely, M.G.; Henri, M.Y.M.; Daniel, K.N.; Claire, E.Z.M.; Richard, N. First Detection and Characterization of Hepatitis E Virus in Sewage Samples in Cameroon. Food Environ. Virol. 2023, 15, 255–261. [Google Scholar] [CrossRef]
  114. Salemane, K.; Coetzee, L.Z.; Pocock, G.; Genthe, B.; Taylor, M.B.; Mans, J. Water-Based Epidemiological Investigation of Hepatitis E Virus in South Africa. Food Environ. Virol. 2024, 16, 338–350. [Google Scholar] [CrossRef]
  115. Rouba, A.; Ansmant, T.; Chaqroun, A.; Challant, J.; Josse, T.; Schvoerer, E.; Gantzer, C.; Bertrand, I.; Hartard, C. First detection of Hepatitis E virus (Rocahepevirus ratti) in French urban wastewater: Potential implications for human contamination. Sci. Total. Environ. 2024, 954, 176805. [Google Scholar] [CrossRef]
  116. Casares-Jimenez, M.; Garcia-Garcia, T.; Suárez-Cárdenas, J.M.; Perez-Jimenez, A.B.; Martín, M.A.; Caballero-Gómez, J.; Michán, C.; Corona-Mata, D.; Risalde, M.A.; Perez-Valero, I.; et al. Correlation of hepatitis E and rat hepatitis E viruses urban wastewater monitoring and clinical cases. Sci. Total. Environ. 2024, 908, 168203. [Google Scholar] [CrossRef]
  117. Di Cola, G.; Fantilli, A.C.; Pisano, M.B.; Ré, V.E. Foodborne transmission of hepatitis A and hepatitis E viruses: A literature review. Int. J. Food Microbiol. 2021, 338, 108986. [Google Scholar] [CrossRef]
  118. Johne, R.; Trojnar, E.; Filter, M.; Hofmann, J. Thermal Stability of Hepatitis E Virus as Estimated by a Cell Culture Method. Appl. Environ. Microbiol. 2016, 82, 4225–4231. [Google Scholar] [CrossRef]
  119. Monini, M.; Ianiro, G.; De Sabato, L.; Bivona, M.; Ostanello, F.; Di Bartolo, I. Persistence of hepatitis E virus (HEV) subtypes 3c and 3e: Long-term cold storage and heat treatments. Food Microbiol. 2024, 121, 104529. [Google Scholar] [CrossRef]
  120. Barnaud, E.; Rogée, S.; Garry, P.; Rose, N.; Pavio, N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Appl. Environ. Microbiol. 2012, 78, 5153–5159. [Google Scholar] [CrossRef] [PubMed]
  121. Feagins, A.R.; Opriessnig, T.; Guenette, D.K.; Halbur, P.G.; Meng, X.J. Inactivation of infectious hepatitis E virus present in commercial pig livers sold in local grocery stores in the United States. Int. J. Food Microbiol. 2008, 123, 32–37. [Google Scholar] [CrossRef]
  122. Harrison, L.; DiCaprio, E. Hepatitis E Virus: An Emerging Foodborne Pathogen. Front. Sustain. Food Syst. 2018, 2, 14. [Google Scholar] [CrossRef]
  123. Rivadulla, E.; Varela, M.F.; Mesquita, J.R.; Nascimento, M.S.J.; Romalde, J.L. Detection of Hepatitis E Virus in Shellfish Harvesting Areas from Galicia (Northwestern Spain). Viruses 2019, 11, 618. [Google Scholar] [CrossRef] [PubMed]
  124. Treagus, S.; Wright, C.; Baker-Austin, C.; Longdon, B.; Lowther, J. The Foodborne Transmission of Hepatitis E Virus to Humans. Food Environ. Virol. 2021, 13, 127–145. [Google Scholar] [CrossRef]
  125. Ijaz, S.; Arnold, E.; Banks, M.; Bendall, R.P.; Cramp, M.E.; Cunningham, R.; Dalton, H.R.; Harrison, T.J.; Hill, S.F.; Macfarlane, L.; et al. Non-travel-associated hepatitis E in England and Wales: Demographic, clinical, and molecular epidemiological characteristics. J. Infect. Dis. 2005, 192, 1166–1172. [Google Scholar] [CrossRef]
  126. Thippornchai, N.; Leaungwutiwong, P.; Kosoltanapiwat, N.; Vuong, C.; Nguyen, K.; Okabayashi, T.; Lee, A. Survey of hepatitis E virus in pork products and pig stools in Nakhon Pathom Province, Thailand. Vet. Med. Sci. 2022, 8, 1975–1981. [Google Scholar] [CrossRef]
  127. Rizzo, C.; Di Bartolo, I.; Santantonio, M.; Coscia, M.F.; Monno, R.; De Vito, D.; Ruggeri, F.M.; Rizzo, G. Epidemiological and virological investigation of a Norovirus outbreak in a resort in Puglia, Italy. BMC Infect. Dis. 2007, 7, 135. [Google Scholar] [CrossRef]
  128. Ferri, G.; Vergara, A. Hepatitis E Virus in the Food of Animal Origin: A Review. Foodborne Pathog. Dis. 2021, 18, 368–377. [Google Scholar] [CrossRef]
  129. Lees, D. Viruses and bivalve shellfish. Int. J. Food Microbiol. 2000, 59, 81–116. [Google Scholar] [CrossRef]
  130. Gao, S.; Li, D.; Zha, E.; Zhou, T.; Wang, S.; Yue, X. Surveillance of Hepatitis E Virus Contamination in Shellfish in China. Int. J. Environ. Res. Public Health 2015, 12, 2026–2036. [Google Scholar] [CrossRef] [PubMed]
  131. Koizumi, Y.; Isoda, N.; Sato, Y.; Iwaki, T.; Ono, K.; Ido, K.; Sugano, K.; Takahashi, M.; Nishizawa, T.; Okamoto, H. Infection of a Japanese patient by genotype 4 hepatitis e virus while traveling in Vietnam. J. Clin. Microbiol. 2004, 42, 3883–3885. [Google Scholar] [CrossRef] [PubMed]
  132. Li, T.-C.; Miyamura, T.; Takeda, N. Detection of hepatitis E virus RNA from the bivalve Yamato-Shijimi (Corbicula japonica) in Japan. Am. J. Trop. Med. Hyg. 2007, 76, 170–172. [Google Scholar] [CrossRef] [PubMed]
  133. O’Hara, Z.; Crossan, C.; Craft, J.; Scobie, L. First Report of the Presence of Hepatitis E Virus in Scottish-Harvested Shellfish Purchased at Retail Level. Food Environ. Virol. 2018, 10, 217–221. [Google Scholar] [CrossRef]
  134. Loisy, F.; Atmar, R.L.; Le Saux, J.-C.; Cohen, J.; Caprais, M.-P.; Pommepuy, M.; Le Guyader, F.S. Use of Rotavirus Virus-Like Particles as Surrogates To Evaluate Virus Persistence in Shellfish. Appl. Environ. Microbiol. 2005, 71, 6049–6053. [Google Scholar] [CrossRef]
  135. Schwab, K.J.; Neill, F.H.; Estes, M.K.; Metcalf, T.G.; Atmar, R.L. Distribution of Norwalk virus within shellfish following bioaccumulation and subsequent depuration by detection using RT-PCR. J. Food Prot. 1998, 61, 1674–1680. [Google Scholar] [CrossRef]
  136. Sané, S.; Diouara, A.A.M.; Coundoul, S.; Tene, S.D.; Kane, A.; Wade, S.F.; Tamba, A.; Diop, M.; Mbaye, M.N.; Thiam, F.; et al. A metagenomic assessment of bacterial community in spices sold open-air markets in Saint-Louis, Senegal. Sci. Rep. 2024, 14, 14709. [Google Scholar] [CrossRef]
  137. Terio, V.; Bottaro, M.; Pavoni, E.; Losio, M.N.; Serraino, A.; Giacometti, F.; Martella, V.; Mottola, A.; Di Pinto, A.; Tantillo, G. Occurrence of hepatitis A and E and norovirus GI and GII in ready-to-eat vegetables in Italy. Int. J. Food Microbiol. 2017, 249, 61–65. [Google Scholar] [CrossRef]
  138. Iaconelli, M.; Muscillo, M.; Della Libera, S.; Fratini, M.; Meucci, L.; De Ceglia, M.; Giacosa, D.; La Rosa, G. One-year Surveillance of Human Enteric Viruses in Raw and Treated Wastewaters, Downstream River Waters, and Drinking Waters. Food Environ. Virol. 2017, 9, 79–88. [Google Scholar] [CrossRef]
  139. La Rosa, G.; Iaconelli, M.; Pourshaban, M.; Muscillo, M. Detection and molecular characterization of noroviruses from five sewage treatment plants in central Italy. Water Res. 2010, 44, 1777–1784. [Google Scholar] [CrossRef] [PubMed]
  140. Petrinca, A.R.; Donia, D.; Pierangeli, A.; Gabrieli, R.; Degener, A.M.; Bonanni, E.; Diaco, L.; Cecchini, G.; Anastasi, P.; Divizia, M. Presence and environmental circulation of enteric viruses in three different wastewater treatment plants. J. Appl. Microbiol. 2009, 106, 1608–1617. [Google Scholar] [CrossRef] [PubMed]
  141. Scavia, G.; Alfonsi, V.; Taffon, S.; Escher, M.; Bruni, R.; Medici, D.D.; Pasquale, S.D.; Guizzardi, S.; Cappelletti, B.; Iannazzo, S.; et al. A large prolonged outbreak of hepatitis A associated with consumption of frozen berries, Italy, 2013–2014. J. Med. Microbiol. 2017, 66, 342–349. [Google Scholar] [CrossRef] [PubMed]
  142. Severi, E.; Verhoef, L.; Thornton, L.; Guzman-Herrador, B.R.; Faber, M.; Sundqvist, L.; Rimhanen-Finne, R.; Roque-Afonso, A.M.; Ngui, S.L.; Allerberger, F.; et al. Large and prolonged food-borne multistate hepatitis A outbreak in Europe associated with consumption of frozen berries, 2013 to 2014. Eurosurveillance 2015, 20, 21192. [Google Scholar] [CrossRef]
  143. Maunula, L.; Kaupke, A.; Vasickova, P.; Söderberg, K.; Kozyra, I.; Lazic, S.; van der Poel, W.H.M.; Bouwknegt, M.; Rutjes, S.; Willems, K.A.; et al. Tracing enteric viruses in the European berry fruit supply chain. Int. J. Food Microbiol. 2013, 167, 177–185. [Google Scholar] [CrossRef]
  144. Guillois, Y.; Abravanel, F.; Miura, T.; Pavio, N.; Vaillant, V.; Lhomme, S.; Le Guyader, F.S.; Rose, N.; Le Saux, J.-C.; King, L.A.; et al. High Proportion of Asymptomatic Infections in an Outbreak of Hepatitis E Associated With a Spit-Roasted Piglet, France, 2013. Clin. Infect. Dis. 2016, 62, 351–357. [Google Scholar] [CrossRef]
  145. Rivero-Juarez, A.; Frias, M.; Martinez-Peinado, A.; Risalde, M.A.; Rodriguez-Cano, D.; Camacho, A.; García-Bocanegra, I.; Cuenca-Lopez, F.; Gomez-Villamandos, J.C.; Rivero, A. Familial Hepatitis E Outbreak Linked to Wild Boar Meat Consumption. Zoonoses Public Health 2017, 64, 561–565. [Google Scholar] [CrossRef]
  146. Santos-Silva, S.; Romalde, J.L.; Bento, J.T.; Cruz, A.V.S.; López-López, P.; Gonçalves, H.M.R.; Van der Poel, W.H.M.; Nascimento, M.S.J.; Rivero-Juarez, A.; Mesquita, J.R. Serological and Molecular Survey of Hepatitis E Virus in Small Ruminants from Central Portugal. Food Environ. Virol. 2024, 16, 516–524. [Google Scholar] [CrossRef]
  147. Mesquita, J.R.; Santos-Ferreira, N.; Ferreira, A.S.; Albuquerque, C.; Nóbrega, C.; Esteves, F.; Cruz, R.; Vala, H.; Nascimento, M.S.J. Increased risk of hepatitis E virus infection in workers occupationally exposed to sheep. Transbound. Emerg. Dis. 2020, 67, 1918–1921. [Google Scholar] [CrossRef]
  148. EFSA Panel on Biological Hazards, (BIOHAZ); Ricci, A.; Allende, A.; Bolton, D.; Chemaly, M.; Davies, R.; Fernandez Escamez, P.S.; Herman, L.; Koutsoumanis, K.; Lindqvist, R.; et al. Public health risks associated with hepatitis E virus (HEV) as a food-borne pathogen. EFSA J. 2017, 15, e04886. [Google Scholar] [CrossRef]
  149. Lin, J.; Karlsson, M.; Olofson, A.-S.; Belák, S.; Malmsten, J.; Dalin, A.-M.; Widén, F.; Norder, H. High Prevalence of Hepatitis E Virus in Swedish Moose—A Phylogenetic Characterization and Comparison of the Virus from Different Regions. PLoS ONE 2015, 10, e0122102. [Google Scholar] [CrossRef]
  150. Montalvo Villalba, M.; Owot, J.C.; Benedito, E.-C.; Corredor, M.B.; Flaquet, P.P.; Frometa, S.S.; Wong, M.S.; Rodríguez Lay, L. de L.Á. Hepatitis E virus genotype 3 in humans and swine, Cuba. Infect. Genet. Evol. 2013, 14, 335–339. [Google Scholar] [CrossRef]
  151. Roth, A.; Lin, J.; Magnius, L.; Karlsson, M.; Belák, S.; Widén, F.; Norder, H. Markers for Ongoing or Previous Hepatitis E Virus Infection Are as Common in Wild Ungulates as in Humans in Sweden. Viruses 2016, 8, 259. [Google Scholar] [CrossRef] [PubMed]
  152. Ahmad, T.; Jin, H.; Dhama, K.; Yatoo, M.I.; Tiwari, R.; Bilal, M.; Dhawan, M.; Emran, T.B.; Alestad, J.H.; Alhani, H.M.; et al. Hepatitis E virus in pigs and the environment: An updated review of public health concerns. Narra J. 2022, 2, e78. [Google Scholar] [CrossRef] [PubMed]
  153. Feurer, C.; Le Roux, A.; Rossel, R.; Barnaud, E.; Dumarest, M.; Garry, P.; Pavio, N. High load of hepatitis E viral RNA in pork livers but absence in pork muscle at French slaughterhouses. Int. J. Food Microbiol. 2018, 264, 25–30. [Google Scholar] [CrossRef] [PubMed]
  154. Montone, A.M.I.; De Sabato, L.; Suffredini, E.; Alise, M.; Zaccherini, A.; Volzone, P.; Di Maro, O.; Neola, B.; Capuano, F.; Di Bartolo, I. Occurrence of HEV-RNA in Italian Regional Pork and Wild Boar Food Products. Food Environ. Virol. 2019, 11, 420–426. [Google Scholar] [CrossRef]
  155. Tene, S.D.; Diouara, A.A.M.; Kane, A.; Sané, S.; Coundoul, S.; Thiam, F.; Nguer, C.M.; Diop, M.; Mbaye, M.N.; Mbengue, M.; et al. Detection of Hepatitis E Virus (HEV) in Pork Sold in Saint-Louis, the North of Senegal. Life 2024, 14, 512. [Google Scholar] [CrossRef]
  156. Antia, R.E.; Adekola, A.A.; Jubril, A.J.; Ohore, O.G.; Emikpe, B.O. Hepatitis E Virus infection seroprevalence and the associated risk factors in animals raised in Ibadan, Nigeria. J. Immunoass. Immunochem. 2018, 39, 509–520. [Google Scholar] [CrossRef]
  157. Bagulo, H.; Majekodunmi, A.O.; Welburn, S.C. Hepatitis E in Sub Saharan Africa—A significant emerging disease. One Health 2021, 11, 100186. [Google Scholar] [CrossRef]
  158. Owolodun, O.A.; Gerber, P.F.; Giménez-Lirola, L.G.; Kwaga, J.K.P.; Opriessnig, T. First Report of Hepatitis E Virus Circulation in Domestic Pigs in Nigeria. Am. J. Trop. Med. Hyg. 2014, 91, 699–704. [Google Scholar] [CrossRef]
  159. Temmam, S.; Besnard, L.; Andriamandimby, S.F.; Foray, C.; Rasamoelina-Andriamanivo, H.; Héraud, J.-M.; Cardinale, E.; Dellagi, K.; Pavio, N.; Pascalis, H.; et al. High Prevalence of Hepatitis E in Humans and Pigs and Evidence of Genotype-3 Virus in Swine, Madagascar. Am. J. Trop. Med. Hyg. 2013, 88, 329–338. [Google Scholar] [CrossRef] [PubMed]
  160. Traoré, K.A.; Ouoba, J.B.; Huot, N.; Rogée, S.; Dumarest, M.; Traoré, A.S.; Pavio, N.; Barro, N.; Roques, P. Hepatitis E Virus Exposure is Increased in Pork Butchers from Burkina Faso. Am. J. Trop. Med. Hyg. 2015, 93, 1356–1359. [Google Scholar] [CrossRef]
  161. Suluku, R.; Jabaty, J.; Fischer, K.; Diederich, S.; Groschup, M.H.; Eiden, M. Hepatitis E Seroprevalence and Detection of Genotype 3 Strains in Domestic Pigs from Sierra Leone Collected in 2016 and 2017. Viruses 2024, 16, 558. [Google Scholar] [CrossRef]
  162. Modiyinji, A.F.; Sanding, G.M.A.M.; Atsama, M.A.; Monamele, C.G.; Nola, M.; Njouom, R. Serological and molecular investigation of hepatitis E virus in pigs reservoirs from Cameroon reveals elevated seroprevalence and presence of genotype 3. PLoS ONE 2020, 15, e0229073. [Google Scholar] [CrossRef]
  163. Nombot-Yazenguet, M.P.d.M.; Modiyinji, A.F.; Tricou, V.; Manirakiza, A.; Njouom, R.; Komas, N.P.J. Investigating animal reservoirs for hepatitis E virus in Bangui, Central African Republic. PLoS ONE 2024, 19, e0300608. [Google Scholar] [CrossRef]
  164. Pavio, N.; Merbah, T.; Thébault, A. Frequent Hepatitis E Virus Contamination in Food Containing Raw Pork Liver, France. Emerg. Infect. Dis. 2014, 20, 1925–1927. [Google Scholar] [CrossRef]
  165. Mykytczuk, O.; Harlow, J.; Bidawid, S.; Corneau, N.; Nasheri, N. Prevalence and Molecular Characterization of the Hepatitis E Virus in Retail Pork Products Marketed in Canada. Food Environ. Virol. 2017, 9, 208–218. [Google Scholar] [CrossRef]
  166. Korsman, S.; Bloemberg, J.; Brombacher, M.; Giuricich, A.; Halley-Stott, R.P.; Kaba, M. Hepatitis E in pig-derived food products in Cape Town, South Africa, 2014. S Afr. Med. J. 2019, 109, 584–586. [Google Scholar] [CrossRef]
  167. Milojević, L.; Velebit, B.; Teodorović, V.; Kirbiš, A.; Petrović, T.; Karabasil, N.; Dimitrijević, M. Screening and Molecular Characterization of Hepatitis E Virus in Slaughter Pigs in Serbia. Food Environ. Virol. 2019, 11, 410–419. [Google Scholar] [CrossRef]
  168. Potemkin, I.A.; Kyuregyan, K.K.; Karlsen, A.A.; Isaeva, O.V.; Kichatova, V.S.; Lopatukhina, M.A.; Asadi Mobarkhan, F.A.; Zlobina, A.G.; Zheltobriukh, A.V.; Bocharova, K.A.; et al. Hepatitis E Virus Infection in Voluntary Blood Donors in the Russian Federation. Viruses 2024, 16, 526. [Google Scholar] [CrossRef]
  169. Tanaka, A.; Matsubayashi, K.; Odajima, T.; Sakata, H.; Iida, J.; Kai, K.; Goto, N.; Satake, M. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan. Transfusion 2024, 64, 335–347. [Google Scholar] [CrossRef]
  170. Vollmer, T.; Diekmann, J.; Knabbe, C.; Dreier, J. Hepatitis E virus blood donor NAT screening: As much as possible or as much as needed? Transfusion 2019, 59, 612–622. [Google Scholar] [CrossRef]
  171. Dreier, J.; Knabbe, C.; Vollmer, T. Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose. Front. Med. 2018, 5, 5. [Google Scholar] [CrossRef]
  172. Al-Sadeq, D.W.; Majdalawieh, A.F.; Nasrallah, G.K. Seroprevalence and incidence of hepatitis E virus among blood donors: A review. Rev. Med. Virol. 2017, 27, e1937. [Google Scholar] [CrossRef] [PubMed]
  173. Matsubayashi, K.; Nagaoka, Y.; Sakata, H.; Sato, S.; Fukai, K.; Kato, T.; Takahashi, K.; Mishiro, S.; Imai, M.; Takeda, N.; et al. Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004, 44, 934–940. [Google Scholar] [CrossRef] [PubMed]
  174. Matsubayashi, K.; Kang, J.-H.; Sakata, H.; Takahashi, K.; Shindo, M.; Kato, M.; Sato, S.; Kato, T.; Nishimori, H.; Tsuji, K.; et al. A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008, 48, 1368–1375. [Google Scholar] [CrossRef] [PubMed]
  175. Tamura, A.; Shimizu, Y.K.; Tanaka, T.; Kuroda, K.; Arakawa, Y.; Takahashi, K.; Mishiro, S.; Shimizu, K.; Moriyama, M. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol. Res. 2007, 37, 113–120. [Google Scholar] [CrossRef]
  176. Coilly, A.; Haïm-Boukobza, S.; Roche, B.; Antonini, T.M.; Pause, A.; Mokhtari, C.; Becq, A.; Farahmand, H.; Hauser, L.; Duclos-Vallée, J.-C.; et al. Posttransplantation hepatitis E: Transfusion-transmitted hepatitis rising from the ashes. Transplantation 2013, 96, e4–e6. [Google Scholar] [CrossRef]
  177. Haïm-Boukobza, S.; Ferey, M.-P.; Vétillard, A.-L.; Jeblaoui, A.; Pélissier, E.; Pelletier, G.; Teillet, L.; Roque-Afonso, A.-M. Transfusion-transmitted hepatitis E in a misleading context of autoimmunity and drug-induced toxicity. J. Hepatol. 2012, 57, 1374–1378. [Google Scholar] [CrossRef]
  178. Hauser, L.; Roque-Afonso, A.-M.; Beylouné, A.; Simonet, M.; Deau Fischer, B.; Burin des Roziers, N.; Mallet, V.; Tiberghien, P.; Bierling, P. Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014, 123, 796–797. [Google Scholar] [CrossRef]
  179. Huzly, D.; Umhau, M.; Bettinger, D.; Cathomen, T.; Emmerich, F.; Hasselblatt, P.; Hengel, H.; Herzog, R.; Kappert, O.; Maassen, S.; et al. Transfusion-transmitted hepatitis E in Germany, 2013. Euro. Surveill. 2014, 19, 20812. [Google Scholar] [CrossRef] [PubMed]
  180. Bi, H.; Yang, R.; Wu, C.; Xia, J. Hepatitis E virus and blood transfusion safety. Epidemiol. Infect. 2020, 148, e158. [Google Scholar] [CrossRef] [PubMed]
  181. Riveiro-Barciela, M.; Mínguez, B.; Gironés, R.; Rodriguez-Frías, F.; Quer, J.; Buti, M. Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion. J. Clin. Gastroenterol. 2015, 49, 165–168. [Google Scholar] [CrossRef] [PubMed]
  182. Izopet, J.; Lhomme, S.; Chapuy-Regaud, S.; Mansuy, J.-M.; Kamar, N.; Abravanel, F. HEV and transfusion-recipient risk. Transfus. Clin. Et. Biol. J. De. La. Soc. Fr. De. Transfus. Sang. 2017, 24, 176–181. [Google Scholar] [CrossRef]
  183. Traoré, K.A.; Ouoba, J.B.; Rouamba, H.; Nébié, Y.K.; Dahourou, H.; Rossetto, F.; Traoré, A.S.; Barro, N.; Roques, P. Hepatitis E Virus Prevalence among Blood Donors, Ouagadougou, Burkina Faso. Emerg. Infect. Dis. J.—CDC 2016, 22, 755. [Google Scholar] [CrossRef]
  184. Wen, G.-P.; Chen, C.-R.; Song, X.-Y.; Tang, Z.-M.; Ji, W.-F.; Wang, S.-L.; Zhang, K.; Zhang, J.; Ou, S.-H.; Zheng, Z.-Z.; et al. Long-term HEV carriers without antibody seroconversion among eligible immunocompetent blood donors. Emerg. Microbes Infect. 2018, 7, 1–8. [Google Scholar] [CrossRef]
  185. Khuroo, M.S.; Kamili, S.; Yattoo, G.N. Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J. Gastroenterol. Hepatol. 2004, 19, 778–784. [Google Scholar] [CrossRef]
  186. Chau, K.H.; Dawson, G.J.; Bile, K.M.; Magnius, L.O.; Sjogren, M.H.; Mushahwar, I.K. Detection of IgA class antibody to hepatitis E virus in serum samples from patients with hepatitis E virus infection. J. Med. Virol. 1993, 40, 334–338. [Google Scholar] [CrossRef]
  187. Elbahrawy, A.; Ibrahim, M.K.; Eliwa, A.; Alboraie, M.; Madian, A.; Aly, H.H. Current situation of viral hepatitis in Egypt. Microbiol. Immunol. 2021, 65, 352–372. [Google Scholar] [CrossRef]
  188. Furukawa, N.W.; Teshale, E.H.; Cosmas, L.; Ochieng, M.; Gikunju, S.; Fields, B.S.; Montgomery, J.M. Serologic evidence for hepatitis E virus infection among patients with undifferentiated acute febrile illness in Kibera, Kenya. J. Clin. Virol. 2016, 77, 106–108. [Google Scholar] [CrossRef]
  189. Madden, R.G.; Wallace, S.; Sonderup, M.; Korsman, S.; Chivese, T.; Gavine, B.; Edem, A.; Govender, R.; English, N.; Kaiyamo, C.; et al. Hepatitis E virus: Western Cape, South Africa. World J. Gastroenterol. 2016, 22, 9853–9859. [Google Scholar] [CrossRef]
  190. Meldal, B.H.M.; Sarkodie, F.; Owusu-Ofori, S.; Allain, J.-P. Hepatitis E virus infection in Ghanaian blood donors—The importance of immunoassay selection and confirmation. Vox Sang. 2013, 104, 30–36. [Google Scholar] [CrossRef]
  191. Traoré, K.A.; Rouamba, H.; Nébié, Y.; Sanou, M.; Traoré, A.S.; Barro, N.; Roques, P. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso. PLoS ONE 2012, 7, e48125. [Google Scholar] [CrossRef]
  192. Hazam, R.K.; Singla, R.; Kishore, J.; Singh, S.; Gupta, R.K.; Kar, P. Surveillance of hepatitis E virus in sewage and drinking water in a resettlement colony of Delhi: What has been the experience? Arch. Virol. 2010, 155, 1227–1233. [Google Scholar] [CrossRef] [PubMed]
  193. Lhomme, S.; Magne, S.; Perelle, S.; Vaissière, E.; Abravanel, F.; Trelon, L.; Hennechart-Collette, C.; Fraisse, A.; Martin-Latil, S.; Izopet, J.; et al. Clustered Cases of Waterborne Hepatitis E Virus Infection, France. Viruses 2023, 15, 1149. [Google Scholar] [CrossRef] [PubMed]
  194. Salvador, D.; Neto, C.; Benoliel, M.J.; Caeiro, M.F. Assessment of the Presence of Hepatitis E Virus in Surface Water and Drinking Water in Portugal. Microorganisms 2020, 8, 761. [Google Scholar] [CrossRef] [PubMed]
  195. Wang, H.; Kjellberg, I.; Sikora, P.; Rydberg, H.; Lindh, M.; Bergstedt, O.; Norder, H. Hepatitis E virus genotype 3 strains and a plethora of other viruses detected in raw and still in tap water. Water Res. 2020, 168, 115141. [Google Scholar] [CrossRef]
  196. Gentry-Shields, J.; Myers, K.; Pisanic, N.; Heaney, C.; Stewart, J. Hepatitis E virus and coliphages in waters proximal to swine concentrated animal feeding operations. Sci. Total Environ. 2015, 505, 487–493. [Google Scholar] [CrossRef]
  197. Steyer, A.; Naglič, T.; Močilnik, T.; Poljšak-Prijatelj, M.; Poljak, M. Hepatitis E virus in domestic pigs and surface waters in Slovenia: Prevalence and molecular characterization of a novel genotype 3 lineage. Infect. Genet. Evol. 2011, 11, 1732–1737. [Google Scholar] [CrossRef]
  198. Brassard, J.; Gagné, M.-J.; Généreux, M.; Côté, C. Detection of Human Food-Borne and Zoonotic Viruses on Irrigated, Field-Grown Strawberries. Appl. Environ. Microbiol. 2012, 78, 3763–3766. [Google Scholar] [CrossRef]
  199. Lange, H.; Øverbø, J.; Borgen, K.; Dudman, S.; Hoddevik, G.; Urdahl, A.M.; Vold, L.; Sjurseth, S.K. Hepatitis E in Norway: Seroprevalence in humans and swine. Epidemiol. Infect. 2017, 145, 181–186. [Google Scholar] [CrossRef]
Figure 1. Flowchart summarizing the research process.
Figure 1. Flowchart summarizing the research process.
Pathogens 14 00704 g001
Figure 2. P. balayani global distribution according to genotypes.
Figure 2. P. balayani global distribution according to genotypes.
Pathogens 14 00704 g002
Figure 3. Rocahepevirus genus global distribution according to genotypes among humans and animals.
Figure 3. Rocahepevirus genus global distribution according to genotypes among humans and animals.
Pathogens 14 00704 g003
Figure 4. Phylogenetic tree describing the genetic diversity of P. balayani. A maximum likelihood (ML) tree [based on the genomic region 5995–6226 relative to NC_001434 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-2 capsid). The tree was constructed using 62 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 70 and 100% are indicated by red dots.
Figure 4. Phylogenetic tree describing the genetic diversity of P. balayani. A maximum likelihood (ML) tree [based on the genomic region 5995–6226 relative to NC_001434 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-2 capsid). The tree was constructed using 62 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 70 and 100% are indicated by red dots.
Pathogens 14 00704 g004
Figure 5. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-1. A maximum likelihood (ML) tree [based on the genomic region 42–4921 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-1). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 571 and 1000 are indicated by red dots.
Figure 5. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-1. A maximum likelihood (ML) tree [based on the genomic region 42–4921 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-1). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 571 and 1000 are indicated by red dots.
Pathogens 14 00704 g005
Figure 6. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-2. A maximum likelihood (ML) tree [based on the genomic region 4949–4921 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-2). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 454 and 1000 are indicated by magenta red dots.
Figure 6. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-2. A maximum likelihood (ML) tree [based on the genomic region 4949–4921 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-2). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 454 and 1000 are indicated by magenta red dots.
Pathogens 14 00704 g006
Figure 7. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-3. A maximum likelihood (ML) tree [based on the genomic region 4938–5246 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-3). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 454 and 1000 are indicated by purple dots.
Figure 7. Phylogenetic tree describing the genetic diversity of R. ratti based on ORF-3. A maximum likelihood (ML) tree [based on the genomic region 4938–5246 relative to NC_038504.1 reference sequence] showing the relationships between HEV genotypes based on partial sequences (ORF-3). The tree was constructed using 37 isolates (with tags: Accessions number_host_genotypes) under the GTR nucleotide substitution model with 4 Gamma categories using PhyML [91] on seaview software v5.0.4 [90]. For branch support, bootstrap values between 454 and 1000 are indicated by purple dots.
Pathogens 14 00704 g007
Figure 8. Different transmission routes of hepatitis E virus (created with BioRender.com, accessed on 27 June 2024).
Figure 8. Different transmission routes of hepatitis E virus (created with BioRender.com, accessed on 27 June 2024).
Pathogens 14 00704 g008
Table 1. Search strategy.
Table 1. Search strategy.
StrategiesSet of Keywords
1“HEV” OR “Hepatitis E” OR “Non-A Non-B”
2“epidemiology” AND “Hepatitis E virus”
3(“blood donor” OR “food” OR “wastewater” OR “drinking water” OR “agriculture”)
4“genotype” AND “Hepatitis E virus”
5 (1 AND 2)“HEV” OR “Hepatitis E” OR “Non-A Non-B” AND “epidemiology”
6 (5 AND 3 AND 4)“HEV” OR “Hepatitis E” OR “Non-A Non-B” AND “epidemiology” AND (“blood donor” OR “food” OR “wastewater” OR “drinking water” OR “agriculture”) AND “genotype”
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Tene, S.D.; Diouara, A.A.M.; Sané, S.; Coundoul, S. Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review. Pathogens 2025, 14, 704. https://doi.org/10.3390/pathogens14070704

AMA Style

Tene SD, Diouara AAM, Sané S, Coundoul S. Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review. Pathogens. 2025; 14(7):704. https://doi.org/10.3390/pathogens14070704

Chicago/Turabian Style

Tene, Sophie Deli, Abou Abdallah Malick Diouara, Sarbanding Sané, and Seynabou Coundoul. 2025. "Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review" Pathogens 14, no. 7: 704. https://doi.org/10.3390/pathogens14070704

APA Style

Tene, S. D., Diouara, A. A. M., Sané, S., & Coundoul, S. (2025). Hepatitis E Virus (HEV) Infection in the Context of the One Health Approach: A Systematic Review. Pathogens, 14(7), 704. https://doi.org/10.3390/pathogens14070704

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop